<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0">
    <channel>
        <title>Drug Topics - Pharmacy News via MedWorm.com</title>
        <description>MedWorm.com provides a medical RSS filtering service. Over 6000 RSS medical sources are combined and output via different filters. This feed contains the latest items from the 'Drug Topics - Pharmacy News' source.</description>
        <link><![CDATA[http://www.medworm.com/rss/search.php?qu=Drug+Topics+-+Pharmacy+News&t=Drug+Topics+-+Pharmacy+News&s=Search&f=source]]></link>
        <lastBuildDate>Thu, 09 Feb 2012 01:31:30 +0100</lastBuildDate>
        <item>
            <title>Cardinal gets temporary restraining order to halt DEA&amp;rsquo;s suspension of Florida distribution
    center</title>
            <link>http://www.medworm.com/index.php?rid=5669473&amp;cid=s_38385_34_f&amp;fid=38385&amp;url=http%3A%2F%2Fdrugtopics.modernmedicine.com%2Fdrugtopics%2FTop%2BNews%2FCardinal-gets-temporary-restraining-order-to-halt-%2FArticleStandard%2FArticle%2Fdetail%2F757906%3FcontextCategoryId%3D47448%26ref%3D25</link>
            <description>Cardinal Health has requested a temporary restraining order to block a Drug Enforcement Administration
  suspension halting controlled-substance shipments from its Lakeland, Fla., distribution center. DEA suspended
  Cardinal&amp;rsquo;s distribution license for the Lakeland facility last Friday. (Source: Drug Topics - Pharmacy News)</description>
            <author>Drug Topics - Pharmacy News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5669473</comments>
            <pubDate>Thu, 09 Feb 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5669473</guid>        </item>
        <item>
            <title>Study: OTC medications save billions for healthcare system</title>
            <link>http://www.medworm.com/index.php?rid=5669479&amp;cid=s_38385_34_f&amp;fid=38385&amp;url=http%3A%2F%2Fdrugtopics.modernmedicine.com%2Fdrugtopics%2FTop%2BNews%2FStudy-OTC-medications-save-billions-for-healthcare%2FArticleStandard%2FArticle%2Fdetail%2F757908%3FcontextCategoryId%3D47448%26ref%3D25</link>
            <description>The U.S. healthcare system saves $6 to $7 for every dollar Americans spend on over-the-counter
  medications, according to a new study released by the Consumer Healthcare Products Association
  recently. (Source: Drug Topics - Pharmacy News)</description>
            <author>Drug Topics - Pharmacy News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5669479</comments>
            <pubDate>Tue, 07 Feb 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5669479</guid>        </item>
        <item>
            <title>Walgreens paying $225 million for parts of BioScrip&amp;rsquo;s business</title>
            <link>http://www.medworm.com/index.php?rid=5669478&amp;cid=s_38385_34_f&amp;fid=38385&amp;url=http%3A%2F%2Fdrugtopics.modernmedicine.com%2Fdrugtopics%2FTop%2BNews%2FWalgreens-paying-225-million-for-parts-of-BioScrip%2FArticleStandard%2FArticle%2Fdetail%2F757907%3FcontextCategoryId%3D47448%26ref%3D25</link>
            <description>Walgreens is acquiring &amp;ldquo;certain assets&amp;rdquo; of BioScrip&amp;rsquo;s
  community specialty pharmacies, centralized specialty, and mail service pharmacy businesses for approximately $225
  million (Source: Drug Topics - Pharmacy News)</description>
            <author>Drug Topics - Pharmacy News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5669478</comments>
            <pubDate>Tue, 07 Feb 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5669478</guid>        </item>
        <item>
            <title>FDA grants priority review to GI agent for controlling diarrhea in HIV/AIDS patients</title>
            <link>http://www.medworm.com/index.php?rid=5669477&amp;cid=s_38385_34_f&amp;fid=38385&amp;url=http%3A%2F%2Fdrugtopics.modernmedicine.com%2Fdrugtopics%2FChains%2B%2526%2BBusiness%2FFDA-grants-priority-review-to-GI-agent-for-control%2FArticleStandard%2FArticle%2Fdetail%2F758084%3FcontextCategoryId%3D47448%26ref%3D25</link>
            <description>FDA has granted priority review to crofelemer 125-mg tablets (Salix Pharmaceuticals) for the control
  and symptomatic relief of diarrhea in patients with HIV/AIDS on anti-retroviral therapy (ART). (Source: Drug Topics - Pharmacy News)</description>
            <author>Drug Topics - Pharmacy News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5669477</comments>
            <pubDate>Tue, 07 Feb 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5669477</guid>        </item>
        <item>
            <title>NACDS Foundation awards 58 scholarships, plans $750,000 more in grants</title>
            <link>http://www.medworm.com/index.php?rid=5669476&amp;cid=s_38385_34_f&amp;fid=38385&amp;url=http%3A%2F%2Fdrugtopics.modernmedicine.com%2Fdrugtopics%2FTop%2BNews%2FNACDS-Foundation-awards-58-scholarships-plans-7500%2FArticleStandard%2FArticle%2Fdetail%2F757910%3FcontextCategoryId%3D47448%26ref%3D25</link>
            <description>The National Association of Chain Drug Stores (NACDS) Foundation has awarded 58 scholarships
  &amp;ndash; totaling $190,000 &amp;ndash; to pharmacy schools representing 42 colleges and schools of
  pharmacy, the foundation announced. (Source: Drug Topics - Pharmacy News)</description>
            <author>Drug Topics - Pharmacy News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5669476</comments>
            <pubDate>Tue, 07 Feb 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5669476</guid>        </item>
        <item>
            <title>NACDS tells Congress its concern about track-and-trace programs</title>
            <link>http://www.medworm.com/index.php?rid=5669475&amp;cid=s_38385_34_f&amp;fid=38385&amp;url=http%3A%2F%2Fdrugtopics.modernmedicine.com%2Fdrugtopics%2FTop%2BNews%2FNACDS-tells-Congress-its-concern-about-track-and-t%2FArticleStandard%2FArticle%2Fdetail%2F757911%3FcontextCategoryId%3D47448%26ref%3D25</link>
            <description>The National Association of Chain Drug Stores (NACDS) expressed its concerns about proposed mandatory
  prescription track-and-trace programs in comments to a Congressional advisory panel recently. (Source: Drug Topics - Pharmacy News)</description>
            <author>Drug Topics - Pharmacy News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5669475</comments>
            <pubDate>Tue, 07 Feb 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5669475</guid>        </item>
        <item>
            <title>Report: Drug costs to rise 3% to 5% this year</title>
            <link>http://www.medworm.com/index.php?rid=5669474&amp;cid=s_38385_34_f&amp;fid=38385&amp;url=http%3A%2F%2Fdrugtopics.modernmedicine.com%2Fdrugtopics%2FTop%2BNews%2FReport-Drug-costs-to-rise-3-to-5-this-year%2FArticleStandard%2FArticle%2Fdetail%2F757909%3FcontextCategoryId%3D47448%26ref%3D25</link>
            <description>U.S. drug expenditures remained relatively flat in 2011, but a new report projects that drug costs
  will rise between 3% and 5% across all healthcare settings this year. . (Source: Drug Topics - Pharmacy News)</description>
            <author>Drug Topics - Pharmacy News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5669474</comments>
            <pubDate>Tue, 07 Feb 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5669474</guid>        </item>
        <item>
            <title>Hospitals, healthcare facilities urged to require staffs to get flu shots</title>
            <link>http://www.medworm.com/index.php?rid=5661369&amp;cid=s_38385_34_f&amp;fid=38385&amp;url=http%3A%2F%2Fdrugtopics.modernmedicine.com%2Fdrugtopics%2FModern%2BMedicine%2BFeature%2BArticles%2FHospitals-healthcare-facilities-urged-to-require-s%2FArticleStandard%2FArticle%2Fdetail%2F757723%3FcontextCategoryId%3D47448%26ref%3D25</link>
            <description>Hospitals and healthcare facilities should require all employees to get an annual flu shot, a group
  representing many of the nation?s largest employers emphasized again at a press conference Wednesday in Washington,
  D.C. (Source: Drug Topics - Pharmacy News)</description>
            <author>Drug Topics - Pharmacy News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5661369</comments>
            <pubDate>Mon, 06 Feb 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5661369</guid>        </item>
        <item>
            <title>FDA approves extended-release tablets for type 2 diabetes</title>
            <link>http://www.medworm.com/index.php?rid=5661370&amp;cid=s_38385_34_f&amp;fid=38385&amp;url=http%3A%2F%2Fdrugtopics.modernmedicine.com%2Fdrugtopics%2FChains%2B%2526%2BBusiness%2FFDA-approves-extended-release-tablets-for-type-2-d%2FArticleStandard%2FArticle%2Fdetail%2F757733%3FcontextCategoryId%3D47448%26ref%3D25</link>
            <description>FDA approved sitagliptin and metformin hydrochloride (HCl) extended-release (Janumet XR, Merck)
  tablets, a new treatment for type 2 diabetes that combines sitagliptin, which is the active component of Januvia
  (sitagliptin), with extended-release metformin. (Source: Drug Topics - Pharmacy News)</description>
            <author>Drug Topics - Pharmacy News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5661370</comments>
            <pubDate>Fri, 03 Feb 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5661370</guid>        </item>
        <item>
            <title>SSRIs increase risk of falls, injuries for elderly patients with dementia</title>
            <link>http://www.medworm.com/index.php?rid=5651595&amp;cid=s_38385_34_f&amp;fid=38385&amp;url=http%3A%2F%2Fdrugtopics.modernmedicine.com%2Fdrugtopics%2FTop%2BNews%2FSSRIs-increase-risk-of-falls-injuries-for-elderly-%2FArticleStandard%2FArticle%2Fdetail%2F757543%3FcontextCategoryId%3D47448%26ref%3D25</link>
            <description>Nursing home residents with dementia who use average doses of selective serotonin reuptake inhibitors
  (SSRIs) are 3 times more likely to have a fall resulting in injury compared with those who don?t use SSRIs,
  according a study published online January 18 in the British Journal of Clinical Pharmacology. (Source: Drug Topics - Pharmacy News)</description>
            <author>Drug Topics - Pharmacy News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5651595</comments>
            <pubDate>Fri, 03 Feb 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5651595</guid>        </item>
        <item>
            <title>FTC blocks Omnicare acquisition of PharMerica</title>
            <link>http://www.medworm.com/index.php?rid=5651603&amp;cid=s_38385_34_f&amp;fid=38385&amp;url=http%3A%2F%2Fdrugtopics.modernmedicine.com%2Fdrugtopics%2FTop%2BNews%2FFTC-blocks-Omnicare-acquisition-of-PharMerica%2FArticleStandard%2FArticle%2Fdetail%2F757541%3FcontextCategoryId%3D47448%26ref%3D25</link>
            <description>The Federal Trade Commission turned thumbs down on Omnicare?s attempted acquisition of competitor
  PharMerica. The agency filed suit in federal court to block the hostile takeover. (Source: Drug Topics - Pharmacy News)</description>
            <author>Drug Topics - Pharmacy News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5651603</comments>
            <pubDate>Thu, 02 Feb 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5651603</guid>        </item>
        <item>
            <title>AMCP objects to proposed reporting requirements for Part D</title>
            <link>http://www.medworm.com/index.php?rid=5651602&amp;cid=s_38385_34_f&amp;fid=38385&amp;url=http%3A%2F%2Fdrugtopics.modernmedicine.com%2Fdrugtopics%2FTop%2BNews%2FAMCP-objects-to-proposed-reporting-requirements-fo%2FArticleStandard%2FArticle%2Fdetail%2F757544%3FcontextCategoryId%3D47448%26ref%3D25</link>
            <description>The Academy of Managed Care Pharmacy is not pleased with changes to the Medicare Part D reporting
  requirements proposed by the Centers for Medicare and Medicaid Services. (Source: Drug Topics - Pharmacy News)</description>
            <author>Drug Topics - Pharmacy News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5651602</comments>
            <pubDate>Thu, 02 Feb 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5651602</guid>        </item>
        <item>
            <title>Researchers warn of IV acetaminophen dosing errors</title>
            <link>http://www.medworm.com/index.php?rid=5651601&amp;cid=s_38385_34_f&amp;fid=38385&amp;url=http%3A%2F%2Fdrugtopics.modernmedicine.com%2Fdrugtopics%2FTop%2BNews%2FResearchers-warn-of-IV-acetaminophen-dosing-errors%2FArticleStandard%2FArticle%2Fdetail%2F757542%3FcontextCategoryId%3D47448%26ref%3D25</link>
            <description>Researchers are warning pediatricians, pediatric hospitalists, and intensivists of the potential for
  intravenous acetaminophen dosing errors, especially in young patients under 2 years old. (Source: Drug Topics - Pharmacy News)</description>
            <author>Drug Topics - Pharmacy News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5651601</comments>
            <pubDate>Thu, 02 Feb 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5651601</guid>        </item>
        <item>
            <title>FDA approves tablets for the treatment of adults with type 2 diabetes</title>
            <link>http://www.medworm.com/index.php?rid=5651600&amp;cid=s_38385_34_f&amp;fid=38385&amp;url=http%3A%2F%2Fdrugtopics.modernmedicine.com%2Fdrugtopics%2FTop%2BNews%2FFDA-approves-tablets-for-the-treatment-of-adults-w%2FArticleStandard%2FArticle%2Fdetail%2F757546%3FcontextCategoryId%3D47448%26ref%3D25</link>
            <description>FDA has approved linagliptin/metformin hydrochloride (Jentadueto, Boehringer Ingelheim and Eli Lilly)
  tablets, a new tablet that provides a single-tablet treatment option, taken twice-daily, for adult patients who
  need to control their blood sugar. (Source: Drug Topics - Pharmacy News)</description>
            <author>Drug Topics - Pharmacy News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5651600</comments>
            <pubDate>Thu, 02 Feb 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5651600</guid>        </item>
        <item>
            <title>Ivacaftor approved by FDA to treat rare form of cystic fibrosis</title>
            <link>http://www.medworm.com/index.php?rid=5651599&amp;cid=s_38385_34_f&amp;fid=38385&amp;url=http%3A%2F%2Fdrugtopics.modernmedicine.com%2Fdrugtopics%2FTop%2BNews%2FIvacaftor-approved-by-FDA-to-treat-rare-form-of-cy%2FArticleStandard%2FArticle%2Fdetail%2F757545%3FcontextCategoryId%3D47448%26ref%3D25</link>
            <description>FDA approved ivacaftor (Kalydeco, Vertex Pharmaceuticals) for the treatment of a rare form of cystic
  fibrosis in patients aged 6 years and older who have the specific G551D mutation in the Cystic Fibrosis
  Transmembrane Regulator gene. (Source: Drug Topics - Pharmacy News)</description>
            <author>Drug Topics - Pharmacy News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5651599</comments>
            <pubDate>Thu, 02 Feb 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5651599</guid>        </item>
        <item>
            <title>Diabetes drug dapagliflozin fails to get approval from FDA</title>
            <link>http://www.medworm.com/index.php?rid=5651598&amp;cid=s_38385_34_f&amp;fid=38385&amp;url=http%3A%2F%2Fdrugtopics.modernmedicine.com%2Fdrugtopics%2FTop%2BNews%2FDiabetes-drug-dapagliflozin-fails-to-get-approval-%2FArticleStandard%2FArticle%2Fdetail%2F757547%3FcontextCategoryId%3D47448%26ref%3D25</link>
            <description>FDA declined approval of the diabetes drug dapagliflozin (Bristol-Myers Squibb and AstraZeneca), based
  on the recommendations of 1 of its advisory committees. (Source: Drug Topics - Pharmacy News)</description>
            <author>Drug Topics - Pharmacy News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5651598</comments>
            <pubDate>Thu, 02 Feb 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5651598</guid>        </item>
        <item>
            <title>Study: Dutasteride slows progression of prostate cancer in low-risk men</title>
            <link>http://www.medworm.com/index.php?rid=5651597&amp;cid=s_38385_34_f&amp;fid=38385&amp;url=http%3A%2F%2Fdrugtopics.modernmedicine.com%2Fdrugtopics%2FTop%2BNews%2FStudy-Dutasteride-slows-progression-of-prostate-ca%2FArticleStandard%2FArticle%2Fdetail%2F757548%3FcontextCategoryId%3D47448%26ref%3D25</link>
            <description>Dutasteride (Avodart, GlaxoSmithKline) delays the progression of prostate cancer in men with low-risk
  prostate cancer, according to a new study. (Source: Drug Topics - Pharmacy News)</description>
            <author>Drug Topics - Pharmacy News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5651597</comments>
            <pubDate>Thu, 02 Feb 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5651597</guid>        </item>
        <item>
            <title>Study: Emergency visits increase risk of infections for long-term care residents</title>
            <link>http://www.medworm.com/index.php?rid=5651596&amp;cid=s_38385_34_f&amp;fid=38385&amp;url=http%3A%2F%2Fdrugtopics.modernmedicine.com%2Fdrugtopics%2FTop%2BNews%2FStudy-Emergency-visits-increase-risk-of-infections%2FArticleStandard%2FArticle%2Fdetail%2F757549%3FcontextCategoryId%3D47448%26ref%3D25</link>
            <description>There was an increased risk of acute infection among long-term care residents who visited hospital
  emergency departments, according to a study published online January 23 in the Canadian Medical Association
  Journal. (Source: Drug Topics - Pharmacy News)</description>
            <author>Drug Topics - Pharmacy News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5651596</comments>
            <pubDate>Thu, 02 Feb 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5651596</guid>        </item>
        <item>
            <title>FDA approves ivacaftor to treat rare form of cystic fibrosis</title>
            <link>http://www.medworm.com/index.php?rid=5651604&amp;cid=s_38385_34_f&amp;fid=38385&amp;url=http%3A%2F%2Fdrugtopics.modernmedicine.com%2Fdrugtopics%2FChains%2B%2526%2BBusiness%2FFDA-approves-ivacaftor-to-treat-rare-form-of-cysti%2FArticleStandard%2FArticle%2Fdetail%2F757493%3FcontextCategoryId%3D47448%26ref%3D25</link>
            <description>FDA approved ivacaftor (Kalydeco, Vertex Pharmaceuticals) for the treatment of a rare form of cystic
  fibrosis in patients aged 6 years and older who have the specific G551D mutation in the Cystic Fibrosis
  Transmembrane Regulator gene. (Source: Drug Topics - Pharmacy News)</description>
            <author>Drug Topics - Pharmacy News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5651604</comments>
            <pubDate>Wed, 01 Feb 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5651604</guid>        </item>
        <item>
            <title>FDA approves axitinib to treat renal cell carcinoma</title>
            <link>http://www.medworm.com/index.php?rid=5651612&amp;cid=s_38385_34_f&amp;fid=38385&amp;url=http%3A%2F%2Fdrugtopics.modernmedicine.com%2Fdrugtopics%2FTop%2BNews%2FFDA-approves-axitinib-to-treat-renal-cell-carcinom%2FArticleStandard%2FArticle%2Fdetail%2F757341%3FcontextCategoryId%3D47448%26ref%3D25</link>
            <description>FDA approved axitinib (Inlyta, Pfizer) to treat patients with an advanced kidney cancer called renal
  cell carcinoma who have not responded to another drug for this type of cancer. (Source: Drug Topics - Pharmacy News)</description>
            <author>Drug Topics - Pharmacy News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5651612</comments>
            <pubDate>Tue, 31 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5651612</guid>        </item>
        <item>
            <title>Retail groups object to proposed federal limits on generic reimbursement</title>
            <link>http://www.medworm.com/index.php?rid=5651611&amp;cid=s_38385_34_f&amp;fid=38385&amp;url=http%3A%2F%2Fdrugtopics.modernmedicine.com%2Fdrugtopics%2FTop%2BNews%2FRetail-groups-object-to-proposed-federal-limits-on%2FArticleStandard%2FArticle%2Fdetail%2F757337%3FcontextCategoryId%3D47448%26ref%3D25</link>
            <description>Two key retail pharmacy groups, the National Association of Chain Drug Stores and the National
  Community Pharmacists Association, have renewed their opposition to proposed federal upper limits for generic drug
  reimbursement under Medicaid. (Source: Drug Topics - Pharmacy News)</description>
            <author>Drug Topics - Pharmacy News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5651611</comments>
            <pubDate>Tue, 31 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5651611</guid>        </item>
        <item>
            <title>ScriptPro pharmacy management software program judged Best in KLAS</title>
            <link>http://www.medworm.com/index.php?rid=5651610&amp;cid=s_38385_34_f&amp;fid=38385&amp;url=http%3A%2F%2Fdrugtopics.modernmedicine.com%2Fdrugtopics%2FTop%2BNews%2FScriptPro-pharmacy-management-software-program-jud%2FArticleStandard%2FArticle%2Fdetail%2F757345%3FcontextCategoryId%3D47448%26ref%3D25</link>
            <description>ScriptPro&amp;rsquo;s Central Pharmacy Management System won a 2011 Best in Klas award for
  Software Solutions (pharmacy, outpatient, retail), the 2 companies announced. (Source: Drug Topics - Pharmacy News)</description>
            <author>Drug Topics - Pharmacy News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5651610</comments>
            <pubDate>Tue, 31 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5651610</guid>        </item>
        <item>
            <title>Personal device for testing lung functions approved by FDA</title>
            <link>http://www.medworm.com/index.php?rid=5651609&amp;cid=s_38385_34_f&amp;fid=38385&amp;url=http%3A%2F%2Fdrugtopics.modernmedicine.com%2Fdrugtopics%2FTop%2BNews%2FPersonal-device-for-testing-lung-functions-approve%2FArticleStandard%2FArticle%2Fdetail%2F757344%3FcontextCategoryId%3D47448%26ref%3D25</link>
            <description>The Spiro PD has been cleared to market by FDA for the use by a patient to test lung function in
  children, adolescents, and adults, the product&amp;rsquo;s developer, PMD Healthcare, announced. (Source: Drug Topics - Pharmacy News)</description>
            <author>Drug Topics - Pharmacy News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5651609</comments>
            <pubDate>Tue, 31 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5651609</guid>        </item>
        <item>
            <title>FDA approves first once-weekly treatment for type 2 diabetes</title>
            <link>http://www.medworm.com/index.php?rid=5651608&amp;cid=s_38385_34_f&amp;fid=38385&amp;url=http%3A%2F%2Fdrugtopics.modernmedicine.com%2Fdrugtopics%2FTop%2BNews%2FFDA-approves-first-once-weekly-treatment-for-type-%2FArticleStandard%2FArticle%2Fdetail%2F757340%3FcontextCategoryId%3D47448%26ref%3D25</link>
            <description>FDA has approved exenatide extended-release for injectable suspension (Bydureon, Amylin and Alkermes)
  &amp;mdash; the first once-weekly treatment for type 2 diabetes. (Source: Drug Topics - Pharmacy News)</description>
            <author>Drug Topics - Pharmacy News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5651608</comments>
            <pubDate>Tue, 31 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5651608</guid>        </item>
        <item>
            <title>FDA approves vismodegib for treating basal cell skin cancer</title>
            <link>http://www.medworm.com/index.php?rid=5651607&amp;cid=s_38385_34_f&amp;fid=38385&amp;url=http%3A%2F%2Fdrugtopics.modernmedicine.com%2Fdrugtopics%2FTop%2BNews%2FFDA-approves-vismodegib-for-treating-basal-cell-sk%2FArticleStandard%2FArticle%2Fdetail%2F757339%3FcontextCategoryId%3D47448%26ref%3D25</link>
            <description>FDA has approved vismodegib (Erivedge, Curtis and Genentech, a member of the Roche Group) for the
  treatment of adult patients with basal cell carcinoma, the most common type of skin cancer. (Source: Drug Topics - Pharmacy News)</description>
            <author>Drug Topics - Pharmacy News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5651607</comments>
            <pubDate>Tue, 31 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5651607</guid>        </item>
        <item>
            <title>Review raises questions about why government stockpiling zanamivir, oseltamivir</title>
            <link>http://www.medworm.com/index.php?rid=5651606&amp;cid=s_38385_34_f&amp;fid=38385&amp;url=http%3A%2F%2Fdrugtopics.modernmedicine.com%2Fdrugtopics%2FTop%2BNews%2FReview-raises-questions-about-why-government-stock%2FArticleStandard%2FArticle%2Fdetail%2F757338%3FcontextCategoryId%3D47448%26ref%3D25</link>
            <description>Zanamivir and oseltamivir (Tamiflu, Roche) can help prevent and treat the symptoms of influenza, but
  there is not enough information to evaluate the drugs&amp;rsquo; safety and efficacy for preventing the spread
  of flu or pneumonia, according to a new review published online January 18. (Source: Drug Topics - Pharmacy News)</description>
            <author>Drug Topics - Pharmacy News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5651606</comments>
            <pubDate>Tue, 31 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5651606</guid>        </item>
        <item>
            <title>Big moves by Walgreens: Drops PSC price, acquires Kmart files in 16 states</title>
            <link>http://www.medworm.com/index.php?rid=5651605&amp;cid=s_38385_34_f&amp;fid=38385&amp;url=http%3A%2F%2Fdrugtopics.modernmedicine.com%2Fdrugtopics%2FTop%2BNews%2FBig-moves-by-Walgreens-Drops-PSC-price-acquires-Km%2FArticleStandard%2FArticle%2Fdetail%2F757342%3FcontextCategoryId%3D47448%26ref%3D25</link>
            <description>Walgreens has taken 2 major steps to grow the customer base of its pharmacies since ending its
  relationship with pharmacy benefits manager Express Scripts on January 1. (Source: Drug Topics - Pharmacy News)</description>
            <author>Drug Topics - Pharmacy News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5651605</comments>
            <pubDate>Tue, 31 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5651605</guid>        </item>
        <item>
            <title>Use of aspirin questioned as primary prevention for CVD</title>
            <link>http://www.medworm.com/index.php?rid=5631230&amp;cid=s_38385_34_f&amp;fid=38385&amp;url=http%3A%2F%2Fdrugtopics.modernmedicine.com%2Fdrugtopics%2FTop%2BNews%2FUse-of-aspirin-questioned-as-primary-prevention-fo%2FArticleStandard%2FArticle%2Fdetail%2F757112%3FcontextCategoryId%3D47448%26ref%3D25</link>
            <description>Aspirin prophylaxis in people without prior cardiovascular disease does not appear to reduce
  cardiovascular death or cancer mortality, however it was associated with reductions in nonfatal myocardial
  infarction, according to the results of a meta-analysis published online January 9 in the Archives of Internal
  Medicine. (Source: Drug Topics - Pharmacy News)</description>
            <author>Drug Topics - Pharmacy News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5631230</comments>
            <pubDate>Fri, 27 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5631230</guid>        </item>
        <item>
            <title>Study: Blood clots likely for as many as 1 in 100 following joint replacements</title>
            <link>http://www.medworm.com/index.php?rid=5631235&amp;cid=s_38385_34_f&amp;fid=38385&amp;url=http%3A%2F%2Fdrugtopics.modernmedicine.com%2Fdrugtopics%2FTop%2BNews%2FStudy-Blood-clots-likely-for-as-many-as-1-in-100-f%2FArticleStandard%2FArticle%2Fdetail%2F757108%3FcontextCategoryId%3D47448%26ref%3D25</link>
            <description>Approximately 1 in 100 patients undergoing total or partial knee replacement surgery and 1 in 200
  patients undergoing total or partial hip replacement surgery will experience a venous thromboembolism event,
  including deep vein thrombosis and pulmonary embolism, before being discharged from the hospital, according to a
  study reported January 18 in the Journal of the American Medical Association. (Source: Drug Topics - Pharmacy News)</description>
            <author>Drug Topics - Pharmacy News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5631235</comments>
            <pubDate>Thu, 26 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5631235</guid>        </item>
        <item>
            <title>Shortening pipeline for Alzheimer&amp;rsquo;s drugs discussed by HHS advisory council</title>
            <link>http://www.medworm.com/index.php?rid=5631234&amp;cid=s_38385_34_f&amp;fid=38385&amp;url=http%3A%2F%2Fdrugtopics.modernmedicine.com%2Fdrugtopics%2FTop%2BNews%2FShortening-pipeline-for-Alzheimerrsquos-drugs-disc%2FArticleStandard%2FArticle%2Fdetail%2F757107%3FcontextCategoryId%3D47448%26ref%3D25</link>
            <description>Getting new Alzheimer&amp;rsquo;s drugs to market quickly was 1 of the initiatives discussed
  during the mid-January meeting of the Advisory Council on Alzheimer&amp;rsquo;s Research, Care, and Services in
  Washington, D.C. (Source: Drug Topics - Pharmacy News)</description>
            <author>Drug Topics - Pharmacy News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5631234</comments>
            <pubDate>Thu, 26 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5631234</guid>        </item>
        <item>
            <title>FDA approves first gel for short-term topical AK therapy</title>
            <link>http://www.medworm.com/index.php?rid=5631233&amp;cid=s_38385_34_f&amp;fid=38385&amp;url=http%3A%2F%2Fdrugtopics.modernmedicine.com%2Fdrugtopics%2FTop%2BNews%2FFDA-approves-first-gel-for-short-term-topical-AK-t%2FArticleStandard%2FArticle%2Fdetail%2F757110%3FcontextCategoryId%3D47448%26ref%3D25</link>
            <description>FDA approved ingenol mebutate (Picato, LEO Pharma) gel (0.015%, 0.05%) for the topical treatment of
  actinic keratosis (AK). It is the first topical AK therapy that can be used for as few as 2 or 3 consecutive
  days. (Source: Drug Topics - Pharmacy News)</description>
            <author>Drug Topics - Pharmacy News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5631233</comments>
            <pubDate>Thu, 26 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5631233</guid>        </item>
        <item>
            <title>New guidelines recommend blood-glucose testing for all hospitalized patients</title>
            <link>http://www.medworm.com/index.php?rid=5631232&amp;cid=s_38385_34_f&amp;fid=38385&amp;url=http%3A%2F%2Fdrugtopics.modernmedicine.com%2Fdrugtopics%2FTop%2BNews%2FNew-guidelines-recommend-blood-glucose-testing-for%2FArticleStandard%2FArticle%2Fdetail%2F757109%3FcontextCategoryId%3D47448%26ref%3D25</link>
            <description>The Endocrine Society recently released new clinical-practice guidelines recommending that all
  patients have their blood-glucose levels tested upon admission to the hospital, even if they haven&amp;rsquo;t
  had a prior diagnosis of diabetes. (Source: Drug Topics - Pharmacy News)</description>
            <author>Drug Topics - Pharmacy News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5631232</comments>
            <pubDate>Thu, 26 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5631232</guid>        </item>
        <item>
            <title>Anti-infective drug shortages affect clinical care, outcomes</title>
            <link>http://www.medworm.com/index.php?rid=5631231&amp;cid=s_38385_34_f&amp;fid=38385&amp;url=http%3A%2F%2Fdrugtopics.modernmedicine.com%2Fdrugtopics%2FTop%2BNews%2FAnti-infective-drug-shortages-affect-clinical-care%2FArticleStandard%2FArticle%2Fdetail%2F757111%3FcontextCategoryId%3D47448%26ref%3D25</link>
            <description>Welcome to the latest public health emergency: Shortages of anti-infective agents. These shortages can
  adversely affect clinical care and patient outcomes, according to a new study. (Source: Drug Topics - Pharmacy News)</description>
            <author>Drug Topics - Pharmacy News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5631231</comments>
            <pubDate>Thu, 26 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5631231</guid>        </item>
        <item>
            <title>Remington Honor Medal to go to director of St. Jude Children's Research Hospital</title>
            <link>http://www.medworm.com/index.php?rid=5631236&amp;cid=s_38385_34_f&amp;fid=38385&amp;url=http%3A%2F%2Fdrugtopics.modernmedicine.com%2Fdrugtopics%2FTop%2BNews%2FRemington-Honor-Medal-to-go-to-director-of-St-Jude%2FArticleStandard%2FArticle%2Fdetail%2F756888%3FcontextCategoryId%3D47448%26ref%3D25</link>
            <description>William Edward Evans, PharmD, director and CEO at St Jude Children&amp;rsquo;s Research Hospital,
  has been selected to receive pharmacy&amp;rsquo;s highest award, the Remington Honor Medal, the American
  Pharmacists Association announced. (Source: Drug Topics - Pharmacy News)</description>
            <author>Drug Topics - Pharmacy News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5631236</comments>
            <pubDate>Tue, 24 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5631236</guid>        </item>
        <item>
            <title>Study: Anti-infective drug shortages affect clinical care, outcomes</title>
            <link>http://www.medworm.com/index.php?rid=5621724&amp;cid=s_38385_34_f&amp;fid=38385&amp;url=http%3A%2F%2Fdrugtopics.modernmedicine.com%2Fdrugtopics%2FTop%2BNews%2FStudy-Anti-infective-drug-shortages-affect-clinica%2FArticleStandard%2FArticle%2Fdetail%2F756882%3FcontextCategoryId%3D47448%26ref%3D25</link>
            <description>Welcome to the latest public health emergency: Shortages of anti-infective agents. These shortages can
  adversely affect clinical care and patient outcomes according to a new study. (Source: Drug Topics - Pharmacy News)</description>
            <author>Drug Topics - Pharmacy News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5621724</comments>
            <pubDate>Tue, 24 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5621724</guid>        </item>
        <item>
            <title>Regions Bank won&amp;rsquo;t require employees to use mail-order pharmacies</title>
            <link>http://www.medworm.com/index.php?rid=5621723&amp;cid=s_38385_34_f&amp;fid=38385&amp;url=http%3A%2F%2Fdrugtopics.modernmedicine.com%2Fdrugtopics%2FTop%2BNews%2FRegions-Bank-wonrsquot-require-employees-to-use-ma%2FArticleStandard%2FArticle%2Fdetail%2F756887%3FcontextCategoryId%3D47448%26ref%3D25</link>
            <description>Regions Bank, which operates 1,800 U.S. banks, recently rescinded its policy requiring employees to
  fill prescription drugs for chronic conditions through mail-order pharmacies. (Source: Drug Topics - Pharmacy News)</description>
            <author>Drug Topics - Pharmacy News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5621723</comments>
            <pubDate>Tue, 24 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5621723</guid>        </item>
        <item>
            <title>GE, Bionime launch GE100 home blood glucose monitor</title>
            <link>http://www.medworm.com/index.php?rid=5621722&amp;cid=s_38385_34_f&amp;fid=38385&amp;url=http%3A%2F%2Fdrugtopics.modernmedicine.com%2Fdrugtopics%2FTop%2BNews%2FGE-Bionime-launch-GE100-home-blood-glucose-monitor%2FArticleStandard%2FArticle%2Fdetail%2F756885%3FcontextCategoryId%3D47448%26ref%3D25</link>
            <description>GE has launched its first product in partnership with the biotechnology medical testing company
  Bionime, a home device for diabetics called the GE100 Blood Glucose Monitoring System. (Source: Drug Topics - Pharmacy News)</description>
            <author>Drug Topics - Pharmacy News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5621722</comments>
            <pubDate>Tue, 24 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5621722</guid>        </item>
        <item>
            <title>Remington Honor award to go to director of St. Jude Children's Research Hospital</title>
            <link>http://www.medworm.com/index.php?rid=5621721&amp;cid=s_38385_34_f&amp;fid=38385&amp;url=http%3A%2F%2Fdrugtopics.modernmedicine.com%2Fdrugtopics%2FTop%2BNews%2FRemington-Honor-award-to-go-to-director-of-St-Jude%2FArticleStandard%2FArticle%2Fdetail%2F756888%3FcontextCategoryId%3D47448%26ref%3D25</link>
            <description>William Edward Evans, PharmD, director and CEO at St Jude Children&amp;rsquo;s Research Hospital,
  has been selected to receive pharmacy&amp;rsquo;s highest award, the Remington Honor Medal, the American
  Pharmacists Association announced. (Source: Drug Topics - Pharmacy News)</description>
            <author>Drug Topics - Pharmacy News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5621721</comments>
            <pubDate>Tue, 24 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5621721</guid>        </item>
        <item>
            <title>NCPDP touts new MTM standards, other safety successes in 2011</title>
            <link>http://www.medworm.com/index.php?rid=5621720&amp;cid=s_38385_34_f&amp;fid=38385&amp;url=http%3A%2F%2Fdrugtopics.modernmedicine.com%2Fdrugtopics%2FTop%2BNews%2FNCPDP-touts-new-MTM-standards-other-safety-success%2FArticleStandard%2FArticle%2Fdetail%2F756883%3FcontextCategoryId%3D47448%26ref%3D25</link>
            <description>Developing new standards for medication therapy management was just one of the initiatives that the
  non-profit National Council for Prescription Drug Programs accomplished last year. (Source: Drug Topics - Pharmacy News)</description>
            <author>Drug Topics - Pharmacy News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5621720</comments>
            <pubDate>Tue, 24 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5621720</guid>        </item>
        <item>
            <title>Actavis launches generic equivalent of long-acting ADHD Drug, with 180-day exclusivity</title>
            <link>http://www.medworm.com/index.php?rid=5621719&amp;cid=s_38385_34_f&amp;fid=38385&amp;url=http%3A%2F%2Fdrugtopics.modernmedicine.com%2Fdrugtopics%2FTop%2BNews%2FActavis-launches-generic-equivalent-of-long-acting%2FArticleStandard%2FArticle%2Fdetail%2F756884%3FcontextCategoryId%3D47448%26ref%3D25</link>
            <description>FDA recently approved methylphenidate hydrochloride extended-release capsules (LA) CII, USP, the
  generic equivalent of Ritalin LA. Actavis Group, an international generic pharmaceuticals company, received
  first-to-file exclusivity on the 20-mg, 30-mg, and 40-mg strengths. (Source: Drug Topics - Pharmacy News)</description>
            <author>Drug Topics - Pharmacy News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5621719</comments>
            <pubDate>Tue, 24 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5621719</guid>        </item>
        <item>
            <title>NCPA to CMS: Offer special enrollment period for seniors who feel they were duped by preferred
    networks</title>
            <link>http://www.medworm.com/index.php?rid=5621718&amp;cid=s_38385_34_f&amp;fid=38385&amp;url=http%3A%2F%2Fdrugtopics.modernmedicine.com%2Fdrugtopics%2FTop%2BNews%2FNCPA-to-CMS-Offer-special-enrollment-period-for-se%2FArticleStandard%2FArticle%2Fdetail%2F756886%3FcontextCategoryId%3D47448%26ref%3D25</link>
            <description>Medicare patients who believe they were duped into enrolling in a &amp;ldquo;preferred
  network&amp;rdquo; with inadequate pharmacy access should be granted a special enrollment period to sign up for
  a new Medicare Part D prescription drug plan, the National Community Pharmacists Association told the federal
  agency in a letter. (Source: Drug Topics - Pharmacy News)</description>
            <author>Drug Topics - Pharmacy News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5621718</comments>
            <pubDate>Tue, 24 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5621718</guid>        </item>
        <item>
            <title>Varicella vaccination program cuts infection rate in infants</title>
            <link>http://www.medworm.com/index.php?rid=5612275&amp;cid=s_38385_34_f&amp;fid=38385&amp;url=http%3A%2F%2Fdrugtopics.modernmedicine.com%2Fdrugtopics%2FTop%2BNews%2FVaricella-vaccination-program-cuts-infection-rate-%2FArticleStandard%2FArticle%2Fdetail%2F756629%3FcontextCategoryId%3D47448%26ref%3D25</link>
            <description>The U.S. varicella vaccination program has substantial indirect benefits for infants, who are not
  eligible to receive the vaccine, a recent report from the Centers for Disease Control and Prevention
  shows. (Source: Drug Topics - Pharmacy News)</description>
            <author>Drug Topics - Pharmacy News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5612275</comments>
            <pubDate>Sat, 21 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5612275</guid>        </item>
        <item>
            <title>New data: ADT does not increase cardiovascular death risk</title>
            <link>http://www.medworm.com/index.php?rid=5612280&amp;cid=s_38385_34_f&amp;fid=38385&amp;url=http%3A%2F%2Fdrugtopics.modernmedicine.com%2Fdrugtopics%2FTop%2BNews%2FNew-data-ADT-does-not-increase-cardiovascular-deat%2FArticleStandard%2FArticle%2Fdetail%2F756630%3FcontextCategoryId%3D47448%26ref%3D25</link>
            <description>Contrary to the conclusions of recent research, androgen deprivation therapy does not appear to raise
  the risk of fatal heart attacks in men being treated for prostate cancer, results from a multicenter study
  indicate (Source: Drug Topics - Pharmacy News)</description>
            <author>Drug Topics - Pharmacy News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5612280</comments>
            <pubDate>Thu, 19 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5612280</guid>        </item>
        <item>
            <title>Voraxaze approved for treating patients with toxic methotrexate levels</title>
            <link>http://www.medworm.com/index.php?rid=5612279&amp;cid=s_38385_34_f&amp;fid=38385&amp;url=http%3A%2F%2Fdrugtopics.modernmedicine.com%2Fdrugtopics%2FTop%2BNews%2FVoraxaze-approved-for-treating-patients-with-toxic%2FArticleStandard%2FArticle%2Fdetail%2F756626%3FcontextCategoryId%3D47448%26ref%3D25</link>
            <description>FDA approved glucarpidase (Voraxaze, BTG International) to treat patients with toxic levels of
  methotrexate in their blood because of kidney failure. (Source: Drug Topics - Pharmacy News)</description>
            <author>Drug Topics - Pharmacy News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5612279</comments>
            <pubDate>Thu, 19 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5612279</guid>        </item>
        <item>
            <title>ACP Foundation hopes tools can help prevent strokes in patients with atrial fibrillation</title>
            <link>http://www.medworm.com/index.php?rid=5612278&amp;cid=s_38385_34_f&amp;fid=38385&amp;url=http%3A%2F%2Fdrugtopics.modernmedicine.com%2Fdrugtopics%2FTop%2BNews%2FACP-Foundation-hopes-tools-can-help-prevent-stroke%2FArticleStandard%2FArticle%2Fdetail%2F756628%3FcontextCategoryId%3D47448%26ref%3D25</link>
            <description>The ACP Foundation recently published a 31-page primer, Initiative on Atrial Fibrillation and Stroke
  Prevention, in the hopes of improving the care of patients with atrial fibrillation within health
  systems. (Source: Drug Topics - Pharmacy News)</description>
            <author>Drug Topics - Pharmacy News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5612278</comments>
            <pubDate>Thu, 19 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5612278</guid>        </item>
        <item>
            <title>FDA recommending 3 user-fee programs to speed drugs to market</title>
            <link>http://www.medworm.com/index.php?rid=5612277&amp;cid=s_38385_34_f&amp;fid=38385&amp;url=http%3A%2F%2Fdrugtopics.modernmedicine.com%2Fdrugtopics%2FTop%2BNews%2FFDA-recommending-3-user-fee-programs-to-speed-drug%2FArticleStandard%2FArticle%2Fdetail%2F756625%3FcontextCategoryId%3D47448%26ref%3D25</link>
            <description>FDA has completed its recommendations to Congress for 3 user-fee programs that will help speed safe
  and effective drugs and lower-cost generic drug and biosimilar biological products to patients. (Source: Drug Topics - Pharmacy News)</description>
            <author>Drug Topics - Pharmacy News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5612277</comments>
            <pubDate>Thu, 19 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5612277</guid>        </item>
        <item>
            <title>RCC agent earns positive review from FDA committee</title>
            <link>http://www.medworm.com/index.php?rid=5612276&amp;cid=s_38385_34_f&amp;fid=38385&amp;url=http%3A%2F%2Fdrugtopics.modernmedicine.com%2Fdrugtopics%2FTop%2BNews%2FRCC-agent-earns-positive-review-from-FDA-committee%2FArticleStandard%2FArticle%2Fdetail%2F756627%3FcontextCategoryId%3D47448%26ref%3D25</link>
            <description>The FDA&amp;rsquo;s Oncologic Drugs Advisory Committee voted unanimously 13 to 0 that data for
  axitinib support a favorable benefit/risk profile for the treatment of patients with advanced renal cell carcinoma
  after failure of a first-line systemic therapy. (Source: Drug Topics - Pharmacy News)</description>
            <author>Drug Topics - Pharmacy News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5612276</comments>
            <pubDate>Thu, 19 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5612276</guid>        </item>
        <item>
            <title>14 senators express concern about limits on Medicaid generic drug reimbursements</title>
            <link>http://www.medworm.com/index.php?rid=5600158&amp;cid=s_38385_34_f&amp;fid=38385&amp;url=http%3A%2F%2Fdrugtopics.modernmedicine.com%2Fdrugtopics%2FTop%2BNews%2F14-senators-express-concern-about-limits-on-Medica%2FArticleStandard%2FArticle%2Fdetail%2F756471%3FcontextCategoryId%3D47448%26ref%3D25</link>
            <description>Fourteen U.S. senators recently expressed their concerns with the Centers for Medicare and Medicaid
  Services&amp;rsquo; proposed Federal Upper Limits for Medicaid generic drug reimbursements. (Source: Drug Topics - Pharmacy News)</description>
            <author>Drug Topics - Pharmacy News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5600158</comments>
            <pubDate>Wed, 18 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5600158</guid>        </item>
        <item>
            <title>Telcare&amp;rsquo;s new blood glucose meter connects patients with pharmacists wirelessly</title>
            <link>http://www.medworm.com/index.php?rid=5600164&amp;cid=s_38385_34_f&amp;fid=38385&amp;url=http%3A%2F%2Fdrugtopics.modernmedicine.com%2Fdrugtopics%2FTop%2BNews%2FTelcarersquos-new-blood-glucose-meter-connects-pat%2FArticleStandard%2FArticle%2Fdetail%2F756469%3FcontextCategoryId%3D47448%26ref%3D25</link>
            <description>Telcare in Bethesda, Md., recently launched a new cellular-enabled glucose meter than transmits
  patients&amp;rsquo; readings to their doctors, pharmacists, or caregivers through wireless
  technology. (Source: Drug Topics - Pharmacy News)</description>
            <author>Drug Topics - Pharmacy News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5600164</comments>
            <pubDate>Tue, 17 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5600164</guid>        </item>
        <item>
            <title>OTC Product News</title>
            <link>http://www.medworm.com/index.php?rid=5600163&amp;cid=s_38385_34_f&amp;fid=38385&amp;url=http%3A%2F%2Fdrugtopics.modernmedicine.com%2Fdrugtopics%2FTop%2BNews%2FOTC-Product-News%2FArticleStandard%2FArticle%2Fdetail%2F756473%3FcontextCategoryId%3D47448%26ref%3D25</link>
            <description>In this section we showcase products and product news that ran up against space limitations or fell
  outside the parameters of recently featured categories in the print edition. (Source: Drug Topics - Pharmacy News)</description>
            <author>Drug Topics - Pharmacy News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5600163</comments>
            <pubDate>Tue, 17 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5600163</guid>        </item>
        <item>
            <title>Study: Smoking-cessation aids don&amp;rsquo;t boost chances of quitting</title>
            <link>http://www.medworm.com/index.php?rid=5600162&amp;cid=s_38385_34_f&amp;fid=38385&amp;url=http%3A%2F%2Fdrugtopics.modernmedicine.com%2Fdrugtopics%2FTop%2BNews%2FStudy-Smoking-cessation-aids-donrsquot-boost-chanc%2FArticleStandard%2FArticle%2Fdetail%2F756470%3FcontextCategoryId%3D47448%26ref%3D25</link>
            <description>A new study found that smokers who use smoking-cessation aids are no more likely to give up cigarettes
  completely than those who do not. (Source: Drug Topics - Pharmacy News)</description>
            <author>Drug Topics - Pharmacy News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5600162</comments>
            <pubDate>Tue, 17 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5600162</guid>        </item>
        <item>
            <title>Apparent death of California&amp;rsquo;s pseudoephedrine bill pleases NACDS</title>
            <link>http://www.medworm.com/index.php?rid=5600161&amp;cid=s_38385_34_f&amp;fid=38385&amp;url=http%3A%2F%2Fdrugtopics.modernmedicine.com%2Fdrugtopics%2FTop%2BNews%2FApparent-death-of-Californiarsquos-pseudoephedrine%2FArticleStandard%2FArticle%2Fdetail%2F756472%3FcontextCategoryId%3D47448%26ref%3D25</link>
            <description>Legislation in California that would require a prescription for over-the-counter products containing
  pseudoephedrine appears to be dead in committee, which pleased the National Association of Chain Drug
  Stores. (Source: Drug Topics - Pharmacy News)</description>
            <author>Drug Topics - Pharmacy News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5600161</comments>
            <pubDate>Tue, 17 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5600161</guid>        </item>
        <item>
            <title>Consumer groups slam PBM merger plans again</title>
            <link>http://www.medworm.com/index.php?rid=5600160&amp;cid=s_38385_34_f&amp;fid=38385&amp;url=http%3A%2F%2Fdrugtopics.modernmedicine.com%2Fdrugtopics%2FTop%2BNews%2FConsumer-groups-slam-PBM-merger-plans-again%2FArticleStandard%2FArticle%2Fdetail%2F756468%3FcontextCategoryId%3D47448%26ref%3D25</link>
            <description>A coalition of consumer groups has again opposed the proposed acquisition of Medco Health Solutions by
  Express Scripts in a letter to the Federal Trade Commission. (Source: Drug Topics - Pharmacy News)</description>
            <author>Drug Topics - Pharmacy News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5600160</comments>
            <pubDate>Tue, 17 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5600160</guid>        </item>
        <item>
            <title>FTC investigation of CVS Caremark concludes with fine for overcharges of Medicare prescription drugs</title>
            <link>http://www.medworm.com/index.php?rid=5600159&amp;cid=s_38385_34_f&amp;fid=38385&amp;url=http%3A%2F%2Fdrugtopics.modernmedicine.com%2Fdrugtopics%2FTop%2BNews%2FFTC-investigation-of-CVS-Caremark-concludes-with-f%2FArticleStandard%2FArticle%2Fdetail%2F756467%3FcontextCategoryId%3D47448%26ref%3D25</link>
            <description>CVS Caremark has agreed to pay $5 million to compensate consumers who purchased coverage for the 2008
  plan year from a Medicare Part D Prescription Drug Plan sponsored by Rx America, a subsidiary of Longs Drug Stores
  Corp., according to a company press release. (Source: Drug Topics - Pharmacy News)</description>
            <author>Drug Topics - Pharmacy News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5600159</comments>
            <pubDate>Tue, 17 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5600159</guid>        </item>
        <item>
            <title>Jet injectors for flu vaccines take a hit</title>
            <link>http://www.medworm.com/index.php?rid=5621734&amp;cid=s_38385_34_f&amp;fid=38385&amp;url=http%3A%2F%2Fdrugtopics.modernmedicine.com%2Fdrugtopics%2FModern%2BMedicine%2BNow%2FJet-injectors-for-flu-vaccine-take-a-hit%2FArticleStandard%2FArticle%2Fdetail%2F756741%3FcontextCategoryId%3D47448%26ref%3D25</link>
            <description>Although some retail pharmacy chains have purchased injector devices for influenza vaccines, they will
  not be able to use them, according to FDA guidance. (Source: Drug Topics - Pharmacy News)</description>
            <author>Drug Topics - Pharmacy News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5621734</comments>
            <pubDate>Sun, 15 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5621734</guid>        </item>
        <item>
            <title>Cardiometabolic disease: (part1)</title>
            <link>http://www.medworm.com/index.php?rid=5621733&amp;cid=s_38385_34_f&amp;fid=38385&amp;url=http%3A%2F%2Fdrugtopics.modernmedicine.com%2Fdrugtopics%2FModern%2BMedicine%2BFeature%2BArticles%2FCardiometabolic-disease-part1%2FArticleStandard%2FArticle%2Fdetail%2F756734%3FcontextCategoryId%3D47448%26ref%3D25</link>
            <description>Cardiometabolic disease, also known as syndrome X or metabolic syndrome, is a chronic medical
  condition that includes risk factors that together can progress to cardiovascular disease. (Source: Drug Topics - Pharmacy News)</description>
            <author>Drug Topics - Pharmacy News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5621733</comments>
            <pubDate>Sun, 15 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5621733</guid>        </item>
        <item>
            <title>Guidelines discourage routine use of heparin prophylaxis in hospitals</title>
            <link>http://www.medworm.com/index.php?rid=5621732&amp;cid=s_38385_34_f&amp;fid=38385&amp;url=http%3A%2F%2Fdrugtopics.modernmedicine.com%2Fdrugtopics%2FModern%2BMedicine%2BNow%2FGuidelines-discourage-routine-use-of-heparin-proph%2FArticleStandard%2FArticle%2Fdetail%2F756732%3FcontextCategoryId%3D47448%26ref%3D25</link>
            <description>New guidelines from the American College of Physicians recommend against the routine use of heparin to
  prevent venous thromboembolism in hospitalized patients. (Source: Drug Topics - Pharmacy News)</description>
            <author>Drug Topics - Pharmacy News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5621732</comments>
            <pubDate>Sun, 15 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5621732</guid>        </item>
        <item>
            <title>Pharmacists and MTM: Move out from behind the counter</title>
            <link>http://www.medworm.com/index.php?rid=5621731&amp;cid=s_38385_34_f&amp;fid=38385&amp;url=http%3A%2F%2Fdrugtopics.modernmedicine.com%2Fdrugtopics%2FModern%2BMedicine%2BNow%2FPharmacists-and-MTM-Move-out-from-behind-the-count%2FArticleStandard%2FArticle%2Fdetail%2F756737%3FcontextCategoryId%3D47448%26ref%3D25</link>
            <description>Nothing is more valuable than observing and interacting with a patient--something that can't be done
  when you're working eyes down on a bench. (Source: Drug Topics - Pharmacy News)</description>
            <author>Drug Topics - Pharmacy News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5621731</comments>
            <pubDate>Sun, 15 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5621731</guid>        </item>
        <item>
            <title>2012 Drug Pipeline: Researchers, industry experts remain optimistic</title>
            <link>http://www.medworm.com/index.php?rid=5621730&amp;cid=s_38385_34_f&amp;fid=38385&amp;url=http%3A%2F%2Fdrugtopics.modernmedicine.com%2Fdrugtopics%2FModern%2BMedicine%2BNow%2F2012-Drug-Pipeline-Researchers-industry-experts-re%2FArticleStandard%2FArticle%2Fdetail%2F756729%3FcontextCategoryId%3D47448%26ref%3D25</link>
            <description>Despite record R&amp;amp;D investment and FDA approvals expedited within the last year,
  biopharmaceutical productivity remains in decline. (Source: Drug Topics - Pharmacy News)</description>
            <author>Drug Topics - Pharmacy News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5621730</comments>
            <pubDate>Sun, 15 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5621730</guid>        </item>
        <item>
            <title>Walgreens and DeKalb Medical join in discharge medication program</title>
            <link>http://www.medworm.com/index.php?rid=5621729&amp;cid=s_38385_34_f&amp;fid=38385&amp;url=http%3A%2F%2Fdrugtopics.modernmedicine.com%2Fdrugtopics%2FModern%2BMedicine%2BNow%2FWalgreens-and-DeKalb-Medical-join-in-discharge-med%2FArticleStandard%2FArticle%2Fdetail%2F756735%3FcontextCategoryId%3D47448%26ref%3D25</link>
            <description>DeKalb Medical and a Walgreens pharmacy in Decatur, Ga., have jointly launched a program to help
  patients being discharged from the hospital manage their medications. (Source: Drug Topics - Pharmacy News)</description>
            <author>Drug Topics - Pharmacy News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5621729</comments>
            <pubDate>Sun, 15 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5621729</guid>        </item>
        <item>
            <title>Conservative prescribing pays off for patients</title>
            <link>http://www.medworm.com/index.php?rid=5621728&amp;cid=s_38385_34_f&amp;fid=38385&amp;url=http%3A%2F%2Fdrugtopics.modernmedicine.com%2Fdrugtopics%2FModern%2BMedicine%2BNow%2FConservative-prescribing-pays-off-for-patients%2FArticleStandard%2FArticle%2Fdetail%2F756740%3FcontextCategoryId%3D47448%26ref%3D25</link>
            <description>Pharmacists play a vital role on the healthcare team and can help physicians with proper
  prescribing. (Source: Drug Topics - Pharmacy News)</description>
            <author>Drug Topics - Pharmacy News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5621728</comments>
            <pubDate>Sun, 15 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5621728</guid>        </item>
        <item>
            <title>Rehabilitating the impaired pharmacist</title>
            <link>http://www.medworm.com/index.php?rid=5621727&amp;cid=s_38385_34_f&amp;fid=38385&amp;url=http%3A%2F%2Fdrugtopics.modernmedicine.com%2Fdrugtopics%2FModern%2BMedicine%2BNow%2FRehabilitating-the-impaired-pharmacist%2FArticleStandard%2FArticle%2Fdetail%2F756738%3FcontextCategoryId%3D47448%26ref%3D25</link>
            <description>Substance abuse is an issue that is often publicized but not fully appreciated. (Source: Drug Topics - Pharmacy News)</description>
            <author>Drug Topics - Pharmacy News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5621727</comments>
            <pubDate>Sun, 15 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5621727</guid>        </item>
        <item>
            <title>FDA approves drugs for BPH, AF</title>
            <link>http://www.medworm.com/index.php?rid=5621726&amp;cid=s_38385_34_f&amp;fid=38385&amp;url=http%3A%2F%2Fdrugtopics.modernmedicine.com%2Fdrugtopics%2FModern%2BMedicine%2BNow%2FFDA-approves-drugs-for-BPH-AF%2FArticleStandard%2FArticle%2Fdetail%2F756733%3FcontextCategoryId%3D47448%26ref%3D25</link>
            <description>FDA has approved tadalafil to treat benign prostatic hyperplasia in patients with or without erectile
  dysfunction and rivaroxaban to reduce the risk of stroke in patients with nonvalvular atrial
  fibrillation. (Source: Drug Topics - Pharmacy News)</description>
            <author>Drug Topics - Pharmacy News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5621726</comments>
            <pubDate>Sun, 15 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5621726</guid>        </item>
        <item>
            <title>Which side of the line are you on?</title>
            <link>http://www.medworm.com/index.php?rid=5621725&amp;cid=s_38385_34_f&amp;fid=38385&amp;url=http%3A%2F%2Fdrugtopics.modernmedicine.com%2Fdrugtopics%2FModern%2BMedicine%2BNow%2FWhich-side-of-the-line-are-you-on%2FArticleStandard%2FArticle%2Fdetail%2F756736%3FcontextCategoryId%3D47448%26ref%3D25</link>
            <description>A fine line divides the 99% you've heard so much about lately and that elite top percentile who
  control and benefit the most from our economic structure. (Source: Drug Topics - Pharmacy News)</description>
            <author>Drug Topics - Pharmacy News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5621725</comments>
            <pubDate>Sun, 15 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5621725</guid>        </item>
        <item>
            <title>Report: Pharmacy students benefit by early introduction to MTM curricula</title>
            <link>http://www.medworm.com/index.php?rid=5586182&amp;cid=s_38385_34_f&amp;fid=38385&amp;url=http%3A%2F%2Fdrugtopics.modernmedicine.com%2Fdrugtopics%2FTop%2BNews%2FReport-Pharmacy-students-benefit-by-early-introduc%2FArticleStandard%2FArticle%2Fdetail%2F755977%3FcontextCategoryId%3D47448%26ref%3D25</link>
            <description>Two pharmacy organizations issued a report aimed at helping colleges and schools of pharmacy develop
  medication therapy management curricula. The study also emphasized the importance of students learning these
  lessons early. (Source: Drug Topics - Pharmacy News)</description>
            <author>Drug Topics - Pharmacy News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5586182</comments>
            <pubDate>Sat, 14 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5586182</guid>        </item>
        <item>
            <title>Combining vitamin D, calcium supplements can reduce fracture risk for older adults</title>
            <link>http://www.medworm.com/index.php?rid=5586184&amp;cid=s_38385_34_f&amp;fid=38385&amp;url=http%3A%2F%2Fdrugtopics.modernmedicine.com%2Fdrugtopics%2FTop%2BNews%2FCombining-vitamin-D-calcium-supplements-can-reduce%2FArticleStandard%2FArticle%2Fdetail%2F755978%3FcontextCategoryId%3D47448%26ref%3D25</link>
            <description>A combination of vitamin D and calcium supplementation can reduce the risk of fractures in older
  adults, according to a study published in the December 20, 2011, issue of the Annals of Internal
  Medicine. (Source: Drug Topics - Pharmacy News)</description>
            <author>Drug Topics - Pharmacy News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5586184</comments>
            <pubDate>Thu, 12 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5586184</guid>        </item>
        <item>
            <title>Pharmacy groups launch initiative to improve care transition</title>
            <link>http://www.medworm.com/index.php?rid=5586183&amp;cid=s_38385_34_f&amp;fid=38385&amp;url=http%3A%2F%2Fdrugtopics.modernmedicine.com%2Fdrugtopics%2FTop%2BNews%2FPharmacy-groups-launch-initiative-to-improve-care-%2FArticleStandard%2FArticle%2Fdetail%2F755976%3FcontextCategoryId%3D47448%26ref%3D25</link>
            <description>Two leading pharmacy groups are combining forces on an initiative that they hope will more effectively
  involve pharmacists in the coordination of care transition and reduce the number of hospital readmissions of
  patients (Source: Drug Topics - Pharmacy News)</description>
            <author>Drug Topics - Pharmacy News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5586183</comments>
            <pubDate>Thu, 12 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5586183</guid>        </item>
        <item>
            <title>Drug shortages hit record levels in 2011; 2012 may not be much better</title>
            <link>http://www.medworm.com/index.php?rid=5586187&amp;cid=s_38385_34_f&amp;fid=38385&amp;url=http%3A%2F%2Fwww.modernmedicine.com%2Fmodernmedicine%2FTop%2BNews%2FDrug-shortages-hit-record-levels-in-2011-2012-may-%2FArticleStandard%2FArticle%2Fdetail%2F755523%3FcontextCategoryId%3D47448%26ref%3D25</link>
            <description>The number of drug shortages soared in 2011, and the organization that tracks shortages is concerned
  about similar shortages in 2012. (Source: Drug Topics - Pharmacy News)</description>
            <author>Drug Topics - Pharmacy News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5586187</comments>
            <pubDate>Tue, 10 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5586187</guid>        </item>
        <item>
            <title>Statins cost 4 times more in U.S. than in U.K.</title>
            <link>http://www.medworm.com/index.php?rid=5586186&amp;cid=s_38385_34_f&amp;fid=38385&amp;url=http%3A%2F%2Fdrugtopics.modernmedicine.com%2Fdrugtopics%2FTop%2BNews%2FStatins-cost-4-times-more-in-US-than-in-UK%2FArticleStandard%2FArticle%2Fdetail%2F755522%3FcontextCategoryId%3D47448%26ref%3D25</link>
            <description>There is now data behind complaints that prescription drugs cost more in the United States than in
  other industrialized nations. A new study found that the cost for drugs used to lower cholesterol is more than 400%
  higher in the United States than in the United Kingdom. (Source: Drug Topics - Pharmacy News)</description>
            <author>Drug Topics - Pharmacy News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5586186</comments>
            <pubDate>Tue, 10 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5586186</guid>        </item>
        <item>
            <title>Novartis recalls OTC products; FDA issues warning about company&amp;rsquo;s opiate products</title>
            <link>http://www.medworm.com/index.php?rid=5586185&amp;cid=s_38385_34_f&amp;fid=38385&amp;url=http%3A%2F%2Fdrugtopics.modernmedicine.com%2Fdrugtopics%2FTop%2BNews%2FNovartis-recalls-OTC-products-FDA-issues-warning-a%2FArticleStandard%2FArticle%2Fdetail%2F755520%3FcontextCategoryId%3D47448%26ref%3D25</link>
            <description>Novartis Consumer Health has recalled some of its OTC drugs such as Excedrin and Bufferin and FDA has
  issued a safety warning about some of the opiate products manufactured by the company at its Lincoln, Neb.,
  plant. (Source: Drug Topics - Pharmacy News)</description>
            <author>Drug Topics - Pharmacy News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5586185</comments>
            <pubDate>Tue, 10 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5586185</guid>        </item>
        <item>
            <title>Vitamin D, calcium supplementation show no affect on mortality, vascular disease in study</title>
            <link>http://www.medworm.com/index.php?rid=5562963&amp;cid=s_38385_34_f&amp;fid=38385&amp;url=http%3A%2F%2Fdrugtopics.modernmedicine.com%2Fdrugtopics%2FTop%2BNews%2FVitamin-D-calcium-supplementation-show-no-affect-o%2FArticleStandard%2FArticle%2Fdetail%2F754887%3FcontextCategoryId%3D47448%26ref%3D25</link>
            <description>Daily vitamin D or calcium supplementation has no impact on mortality, vascular disease, cancer
  mortality, or cancer incidence, according to the results of a study published online November 23, 2011, in the
  Journal of Clinical Endocrinology &amp;amp; Metabolism. (Source: Drug Topics - Pharmacy News)</description>
            <author>Drug Topics - Pharmacy News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5562963</comments>
            <pubDate>Fri, 06 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5562963</guid>        </item>
        <item>
            <title>No observed clinical benefit for adding niacin to statins, halted study reports</title>
            <link>http://www.medworm.com/index.php?rid=5562967&amp;cid=s_38385_34_f&amp;fid=38385&amp;url=http%3A%2F%2Fdrugtopics.modernmedicine.com%2Fdrugtopics%2FTop%2BNews%2FNo-observed-clinical-benefit-for-adding-niacin-to-%2FArticleStandard%2FArticle%2Fdetail%2F754886%3FcontextCategoryId%3D47448%26ref%3D25</link>
            <description>Extended-release niacin demonstrated no clinical benefit as an add-on therapy to statins in patients
  with established coronary heart disease and low levels of baseline HDL cholesterol, according to the results of a
  study published December 15, 2011 in the New England Journal of Medicine. (Source: Drug Topics - Pharmacy News)</description>
            <author>Drug Topics - Pharmacy News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5562967</comments>
            <pubDate>Thu, 05 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5562967</guid>        </item>
        <item>
            <title>FDA revises simvastatin dose when combined with amiodarone</title>
            <link>http://www.medworm.com/index.php?rid=5562966&amp;cid=s_38385_34_f&amp;fid=38385&amp;url=http%3A%2F%2Fdrugtopics.modernmedicine.com%2Fdrugtopics%2FTop%2BNews%2FFDA-revises-simvastatin-dose-when-combined-with-am%2FArticleStandard%2FArticle%2Fdetail%2F754884%3FcontextCategoryId%3D47448%26ref%3D25</link>
            <description>FDA revised the dose limitation for simvastatin from 10 mg to 20 mg when it is co-administered with
  the cardiac drug amiodarone and the drug labels for Zocor and generics as well as Vytorin have been updated to
  reflect this correction, according to a Drug Safety Communication issued by the agency on December 15,
  2011. (Source: Drug Topics - Pharmacy News)</description>
            <author>Drug Topics - Pharmacy News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5562966</comments>
            <pubDate>Thu, 05 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5562966</guid>        </item>
        <item>
            <title>FDA warns about dronedarone in AF patients</title>
            <link>http://www.medworm.com/index.php?rid=5562965&amp;cid=s_38385_34_f&amp;fid=38385&amp;url=http%3A%2F%2Fdrugtopics.modernmedicine.com%2Fdrugtopics%2FTop%2BNews%2FFDA-warns-about-dronedarone-in-AF-patients%2FArticleStandard%2FArticle%2Fdetail%2F754883%3FcontextCategoryId%3D47448%26ref%3D25</link>
            <description>FDA recently warned that dronedarone (Multaq, Sanofi-Aventis) increases the risk of serious
  cardiovascular events&amp;ndash;including death&amp;ndash;when used by patients in permanent atrial
  fibrillation. (Source: Drug Topics - Pharmacy News)</description>
            <author>Drug Topics - Pharmacy News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5562965</comments>
            <pubDate>Thu, 05 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5562965</guid>        </item>
        <item>
            <title>C. difficile recurrence less frequent with fidaxomicin than vancomycin, review shows</title>
            <link>http://www.medworm.com/index.php?rid=5562964&amp;cid=s_38385_34_f&amp;fid=38385&amp;url=http%3A%2F%2Fdrugtopics.modernmedicine.com%2Fdrugtopics%2FTop%2BNews%2FemC-difficileem-recurrence-less-frequent-with-fida%2FArticleStandard%2FArticle%2Fdetail%2F754885%3FcontextCategoryId%3D47448%26ref%3D25</link>
            <description>The reoccurrence of Clostridium difficile infection is less frequent with fidaxomicin than with
  vancomycin, according to a new review of the effectiveness of C. difficile treatments. (Source: Drug Topics - Pharmacy News)</description>
            <author>Drug Topics - Pharmacy News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5562964</comments>
            <pubDate>Thu, 05 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5562964</guid>        </item>
        <item>
            <title>FDA approves extended use of pneumococcal conjugate vaccine as a single dose to adults 50 years and
    older</title>
            <link>http://www.medworm.com/index.php?rid=5562970&amp;cid=s_38385_34_f&amp;fid=38385&amp;url=http%3A%2F%2Fwww.modernmedicine.com%2Fmodernmedicine%2FFDA%2FFDA-approves-extended-use-of-pneumococcal-conjugat%2FArticleStandard%2FArticle%2Fdetail%2F754779%3FcontextCategoryId%3D47448%26ref%3D25</link>
            <description>FDA has approved Pneumococcal 13-valent Conjugate Vaccine [Diphtheria CRM197 Protein] (Prevnar 13,
  Pfizer) as a single dose for use in adults aged 50 years and older. (Source: Drug Topics - Pharmacy News)</description>
            <author>Drug Topics - Pharmacy News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5562970</comments>
            <pubDate>Wed, 04 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5562970</guid>        </item>
        <item>
            <title>Medicare Advantage changes begin to bite</title>
            <link>http://www.medworm.com/index.php?rid=5562969&amp;cid=s_38385_34_f&amp;fid=38385&amp;url=http%3A%2F%2Fdrugtopics.modernmedicine.com%2Fdrugtopics%2FChains%2B%2526%2BBusiness%2FMedicare-Advantage-changes-begin-to-bite%2FArticleStandard%2FArticle%2Fdetail%2F754803%3FcontextCategoryId%3D47448%26ref%3D25</link>
            <description>Patients are starting to see the first major changes to Medicare required by the Affordable Care Act.
  The biggest changes are coming to Medicare Advantage plans. (Source: Drug Topics - Pharmacy News)</description>
            <author>Drug Topics - Pharmacy News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5562969</comments>
            <pubDate>Wed, 04 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5562969</guid>        </item>
        <item>
            <title>U.S. deaths from Rx overdoses outnumber deaths from heroin and cocaine combined</title>
            <link>http://www.medworm.com/index.php?rid=5562968&amp;cid=s_38385_34_f&amp;fid=38385&amp;url=http%3A%2F%2Fdrugtopics.modernmedicine.com%2Fdrugtopics%2FClinical%2BNews%2FUS-deaths-from-Rx-overdoses-outnumber-deaths-from-%2FArticleStandard%2FArticle%2Fdetail%2F754807%3FcontextCategoryId%3D47448%26ref%3D25</link>
            <description>More Americans die from overdoses of prescription drugs than they do from heroin and cocaine combined,
  according to new data from the Centers for Disease Control and Prevention (CDC). (Source: Drug Topics - Pharmacy News)</description>
            <author>Drug Topics - Pharmacy News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5562968</comments>
            <pubDate>Wed, 04 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5562968</guid>        </item>
        <item>
            <title>Varicella vaccination program cuts infection rate in infants, report shows</title>
            <link>http://www.medworm.com/index.php?rid=5562973&amp;cid=s_38385_34_f&amp;fid=38385&amp;url=http%3A%2F%2Fdrugtopics.modernmedicine.com%2Fdrugtopics%2FTop%2BNews%2FVaricella-vaccination-program-cuts-infection-rate-%2FArticleStandard%2FArticle%2Fdetail%2F754531%3FcontextCategoryId%3D47448%26ref%3D25</link>
            <description>The U.S. varicella vaccination program has substantial indirect benefits for infants who are not
  eligible to receive the vaccine, a new report from the Centers for Disease Control and Prevention
  shows. (Source: Drug Topics - Pharmacy News)</description>
            <author>Drug Topics - Pharmacy News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5562973</comments>
            <pubDate>Tue, 03 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5562973</guid>        </item>
        <item>
            <title>New data: ADT does not increase cardiovascular death risk</title>
            <link>http://www.medworm.com/index.php?rid=5562972&amp;cid=s_38385_34_f&amp;fid=38385&amp;url=http%3A%2F%2Fdrugtopics.modernmedicine.com%2Fdrugtopics%2FTop%2BNews%2FNew-data-ADT-does-not-increase-cardiovascular-deat%2FArticleStandard%2FArticle%2Fdetail%2F754532%3FcontextCategoryId%3D47448%26ref%3D25</link>
            <description>Contrary to the conclusions of recent research, androgen deprivation therapy does not appear to raise
  the risk of fatal heart attacks in men being treated for prostate cancer, according to a study published in
  JAMA. (Source: Drug Topics - Pharmacy News)</description>
            <author>Drug Topics - Pharmacy News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5562972</comments>
            <pubDate>Tue, 03 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5562972</guid>        </item>
        <item>
            <title>Groups oppose CMS' LTC consultant pharmacists proposal</title>
            <link>http://www.medworm.com/index.php?rid=5562971&amp;cid=s_38385_34_f&amp;fid=38385&amp;url=http%3A%2F%2Fdrugtopics.modernmedicine.com%2Fdrugtopics%2FTop%2BNews%2FGroups-oppose-CMS-LTC-consultant-pharmacists-propo%2FArticleStandard%2FArticle%2Fdetail%2F754530%3FcontextCategoryId%3D47448%26ref%3D25</link>
            <description>Pharmacists groups strongly oppose the Centers for Medicare and Medicaid Services? proposal to require
  long-term care (LTC) facilities to contract solely with consultant pharmacists who have no affiliation with any
  in-facility LTC pharmacy, pharmaceutical manufacturer, or drug wholesaler. (Source: Drug Topics - Pharmacy News)</description>
            <author>Drug Topics - Pharmacy News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5562971</comments>
            <pubDate>Tue, 03 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5562971</guid>        </item>
        <item>
            <title>FDA investigating death following first dose of MS drug</title>
            <link>http://www.medworm.com/index.php?rid=5527954&amp;cid=s_38385_34_f&amp;fid=38385&amp;url=http%3A%2F%2Fdrugtopics.modernmedicine.com%2Fdrugtopics%2FTop%2BNews%2FFDA-investigating-death-following-first-dose-of-MS%2FArticleStandard%2FArticle%2Fdetail%2F753889%3FcontextCategoryId%3D47448%26ref%3D25</link>
            <description>FDA announced that it is evaluating the case of a patient with multiple sclerosis (MS) who died 24
  hours following administration of the first dose of fingolimod (Gilenya) (Source: Drug Topics - Pharmacy News)</description>
            <author>Drug Topics - Pharmacy News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5527954</comments>
            <pubDate>Thu, 22 Dec 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5527954</guid>        </item>
        <item>
            <title>CDPH&amp;rsquo;s ASP promotes appropriate use of antimicrobials</title>
            <link>http://www.medworm.com/index.php?rid=5527953&amp;cid=s_38385_34_f&amp;fid=38385&amp;url=http%3A%2F%2Fdrugtopics.modernmedicine.com%2Fdrugtopics%2FTop%2BNews%2FCDPHrsquos-ASP-promotes-appropriate-use-of-antimic%2FArticleStandard%2FArticle%2Fdetail%2F753797%3FcontextCategoryId%3D47448%26ref%3D25</link>
            <description>The California Department of Public Health created the California Antimicrobial Stewardship Program
  (ASP) to educate healthcare facilities about the proper use of antibiotics and is developing statewide
  recommendations for ASPs. (Source: Drug Topics - Pharmacy News)</description>
            <author>Drug Topics - Pharmacy News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5527953</comments>
            <pubDate>Thu, 22 Dec 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5527953</guid>        </item>
        <item>
            <title>FDA modifies REMS for 2 platelet-booster drugs</title>
            <link>http://www.medworm.com/index.php?rid=5527952&amp;cid=s_38385_34_f&amp;fid=38385&amp;url=http%3A%2F%2Fdrugtopics.modernmedicine.com%2Fdrugtopics%2FTop%2BNews%2FFDA-modifies-REMS-for-2-platelet-booster-drugs%2FArticleStandard%2FArticle%2Fdetail%2F753798%3FcontextCategoryId%3D47448%26ref%3D25</link>
            <description>FDA announced changes to the Risk Evaluation and Mitigation Strategies for both Nplate (romiplostim)
  and Promacta (eltrombopag). (Source: Drug Topics - Pharmacy News)</description>
            <author>Drug Topics - Pharmacy News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5527952</comments>
            <pubDate>Thu, 22 Dec 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5527952</guid>        </item>
        <item>
            <title>Shareholders approve Medco, Express Scripts merger</title>
            <link>http://www.medworm.com/index.php?rid=5562974&amp;cid=s_38385_34_f&amp;fid=38385&amp;url=http%3A%2F%2Fdrugtopics.modernmedicine.com%2Fdrugtopics%2FThe%2BLatest%2FShareholders-approve-Medco-Express-Scripts-merger%2FArticleStandard%2FArticle%2Fdetail%2F753815%3FcontextCategoryId%3D47448%26ref%3D25</link>
            <description>Shareholders have overwhelmingly approved the proposed acquisition of Medco Health Solutions by
  Express Scripts, Inc. Both companies held special shareholder meetings in December to approve the $25 billion
  deal. (Source: Drug Topics - Pharmacy News)</description>
            <author>Drug Topics - Pharmacy News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5562974</comments>
            <pubDate>Wed, 21 Dec 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5562974</guid>        </item>
        <item>
            <title>Senate hearing investigates drug shortages</title>
            <link>http://www.medworm.com/index.php?rid=5527956&amp;cid=s_38385_34_f&amp;fid=38385&amp;url=http%3A%2F%2Fdrugtopics.modernmedicine.com%2Fdrugtopics%2FThe%2BLatest%2FSenate-hearing-investigates-drug-shortages%2FArticleStandard%2FArticle%2Fdetail%2F753805%3FcontextCategoryId%3D47448%26ref%3D25</link>
            <description>A Senate hearing December 15 reflected the alarm many in Washington are feeling about the drug
  shortages around the country, but also mirrored the confusion that continues to surround all the causes and any
  possible solutions. (Source: Drug Topics - Pharmacy News)</description>
            <author>Drug Topics - Pharmacy News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5527956</comments>
            <pubDate>Wed, 21 Dec 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5527956</guid>        </item>
        <item>
            <title>Breaking news: Shareholders approve Medco, Express Scripts merger</title>
            <link>http://www.medworm.com/index.php?rid=5527955&amp;cid=s_38385_34_f&amp;fid=38385&amp;url=http%3A%2F%2Fdrugtopics.modernmedicine.com%2Fdrugtopics%2FThe%2BLatest%2FBreaking-news-Shareholders-approve-Medco-Express-S%2FArticleStandard%2FArticle%2Fdetail%2F753815%3FcontextCategoryId%3D47448%26ref%3D25</link>
            <description>Shareholders have overwhelmingly approved the proposed acquisition of Medco Health Solutions by
  Express Scripts, Inc. Both companies held special shareholder meetings in December to approve the $25 billion
  deal. (Source: Drug Topics - Pharmacy News)</description>
            <author>Drug Topics - Pharmacy News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5527955</comments>
            <pubDate>Wed, 21 Dec 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5527955</guid>        </item>
        <item>
            <title>CDC, partners launch child prescription safety campaign</title>
            <link>http://www.medworm.com/index.php?rid=5527959&amp;cid=s_38385_34_f&amp;fid=38385&amp;url=http%3A%2F%2Fdrugtopics.modernmedicine.com%2Fdrugtopics%2FTop%2BNews%2FCDC-partners-launch-child-prescription-safety-camp%2FArticleStandard%2FArticle%2Fdetail%2F753399%3FcontextCategoryId%3D47448%26ref%3D25</link>
            <description>The Centers for Disease Control and Prevention and several other organizations recently launched an
  education program about safe medication storage around children and what to do in the event of an
  emergency. (Source: Drug Topics - Pharmacy News)</description>
            <author>Drug Topics - Pharmacy News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5527959</comments>
            <pubDate>Tue, 20 Dec 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5527959</guid>        </item>
        <item>
            <title>New York law stops mail-order pharmacy mandate</title>
            <link>http://www.medworm.com/index.php?rid=5527958&amp;cid=s_38385_34_f&amp;fid=38385&amp;url=http%3A%2F%2Fwww.modernmedicine.com%2Fmodernmedicine%2FTop%2BNews%2FNew-York-law-stops-mail-order-pharmacy-mandate%2FArticleStandard%2FArticle%2Fdetail%2F753396%3FcontextCategoryId%3D47448%26ref%3D25</link>
            <description>Independent pharmacies in New York can breathe a sigh of relief with the passage of the Anti-Mandatory
  Mail Order Bill, which allows consumers the choice of where to fill their prescriptions. (Source: Drug Topics - Pharmacy News)</description>
            <author>Drug Topics - Pharmacy News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5527958</comments>
            <pubDate>Tue, 20 Dec 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5527958</guid>        </item>
        <item>
            <title>OTC Product News</title>
            <link>http://www.medworm.com/index.php?rid=5527957&amp;cid=s_38385_34_f&amp;fid=38385&amp;url=http%3A%2F%2Fdrugtopics.modernmedicine.com%2Fdrugtopics%2FTop%2BNews%2FOTC-Product-News%2FArticleStandard%2FArticle%2Fdetail%2F753409%3FcontextCategoryId%3D47448%26ref%3D25</link>
            <description>In this section we showcase products and product news that ran up against space limitations or fell
  outside the parameters of recently featured categories in the print edition. (Source: Drug Topics - Pharmacy News)</description>
            <author>Drug Topics - Pharmacy News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5527957</comments>
            <pubDate>Tue, 20 Dec 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5527957</guid>        </item>
        <item>
            <title>Ned's December pick: Case of the year</title>
            <link>http://www.medworm.com/index.php?rid=5507606&amp;cid=s_38385_34_f&amp;fid=38385&amp;url=http%3A%2F%2Fdrugtopics.modernmedicine.com%2Fdrugtopics%2FCommunity%2BPractice%2FNeds-December-pick-Pharmacy-case-of-the-year%2FArticleStandard%2FArticle%2Fdetail%2F752482%3FcontextCategoryId%3D47448%26ref%3D25</link>
            <description>Earlier this year, the Supreme Court handed down a 6-3 decision, striking down a Vermont law that
  restricted the marketing of drugs to prescribers if that marketing was based on the data-mined histories of the
  prescribers' Rx-writing. (Source: Drug Topics - Pharmacy News)</description>
            <author>Drug Topics - Pharmacy News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5507606</comments>
            <pubDate>Fri, 16 Dec 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5507606</guid>        </item>
        <item>
            <title>FDA approves lower-dose topical oxybutynin gel 3% for overactive bladder</title>
            <link>http://www.medworm.com/index.php?rid=5527960&amp;cid=s_38385_34_f&amp;fid=38385&amp;url=http%3A%2F%2Fwww.modernmedicine.com%2Fmodernmedicine%2FFDA%2FFDA-approves-lower-dose-topical-oxybutynin-gel-3-f%2FArticleStandard%2FArticle%2Fdetail%2F752643%3FcontextCategoryId%3D47448%26ref%3D25</link>
            <description>FDA has approved Antares' topical oxybutynin gel 3% product for the treatment of overactive bladder
  (OAB) with symptoms of urge urinary incontinence, urgency, and frequency. (Source: Drug Topics - Pharmacy News)</description>
            <author>Drug Topics - Pharmacy News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5527960</comments>
            <pubDate>Thu, 15 Dec 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5527960</guid>        </item>
        <item>
            <title>NACDS appoints Kathleen Jaeger to newly created post</title>
            <link>http://www.medworm.com/index.php?rid=5507627&amp;cid=s_38385_34_f&amp;fid=38385&amp;url=http%3A%2F%2Fdrugtopics.modernmedicine.com%2Fdrugtopics%2FTop%2BNews%2FNACDS-appoints-Kathleen-Jaeger-to-newly-created-po%2FArticleStandard%2FArticle%2Fdetail%2F752470%3FcontextCategoryId%3D47448%26ref%3D25</link>
            <description>Pharmacy association veteran Kathleen Jaeger will publicly advance the role of pharmacists in patient
  care in the newly created position of senior vice president of pharmacy care and patient advocacy at
  NACDS. (Source: Drug Topics - Pharmacy News)</description>
            <author>Drug Topics - Pharmacy News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5507627</comments>
            <pubDate>Thu, 15 Dec 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5507627</guid>        </item>
        <item>
            <title>Letters December 2011</title>
            <link>http://www.medworm.com/index.php?rid=5507626&amp;cid=s_38385_34_f&amp;fid=38385&amp;url=http%3A%2F%2Fdrugtopics.modernmedicine.com%2Fdrugtopics%2FLetters%2FLetters-December-2011%2FArticleStandard%2FArticle%2Fdetail%2F752560%3FcontextCategoryId%3D47448%26ref%3D25</link>
            <description>Readers sound off on 14-hour shifts, the effectiveness of Alzheimer's meds, and the SAD state of
  pharmacists' eating habits. (Source: Drug Topics - Pharmacy News)</description>
            <author>Drug Topics - Pharmacy News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5507626</comments>
            <pubDate>Thu, 15 Dec 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5507626</guid>        </item>
        <item>
            <title>Simplifying patient meds benefits pharmacy bottom line</title>
            <link>http://www.medworm.com/index.php?rid=5507625&amp;cid=s_38385_34_f&amp;fid=38385&amp;url=http%3A%2F%2Fdrugtopics.modernmedicine.com%2Fdrugtopics%2FCommunity%2BPractice%2FSimplifying-patient-meds-benefits-pharmacy-bottom-%2FArticleStandard%2FArticle%2Fdetail%2F752467%3FcontextCategoryId%3D47448%26ref%3D25</link>
            <description>Many studies have found that getting patients to adhere to their treatment regimens is key to
  improving health outcomes and reducing wasted money and medications. (Source: Drug Topics - Pharmacy News)</description>
            <author>Drug Topics - Pharmacy News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5507625</comments>
            <pubDate>Thu, 15 Dec 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5507625</guid>        </item>
        <item>
            <title>Optimism persists</title>
            <link>http://www.medworm.com/index.php?rid=5507624&amp;cid=s_38385_34_f&amp;fid=38385&amp;url=http%3A%2F%2Fdrugtopics.modernmedicine.com%2Fdrugtopics%2FChains%2B%2526%2BBusiness%2FDrug-Topics-2012-Business-Outlook-Survey-Optimism-%2FArticleStandard%2FArticle%2Fdetail%2F752478%3FcontextCategoryId%3D47448%26ref%3D25</link>
            <description>Drug Topics' 2012 Business Outlok Survey shows that while dollars may be tight, pharmacists continue
  to stay the course. (Source: Drug Topics - Pharmacy News)</description>
            <author>Drug Topics - Pharmacy News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5507624</comments>
            <pubDate>Thu, 15 Dec 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5507624</guid>        </item>
        <item>
            <title>Renewing the patient contract</title>
            <link>http://www.medworm.com/index.php?rid=5507623&amp;cid=s_38385_34_f&amp;fid=38385&amp;url=http%3A%2F%2Fdrugtopics.modernmedicine.com%2Fdrugtopics%2FCommunity%2BPractice%2FRenewing-the-pharmacy-patient-contract%2FArticleStandard%2FArticle%2Fdetail%2F752481%3FcontextCategoryId%3D47448%26ref%3D25</link>
            <description>The end of the year is a good time to think about how we can better serve our patients in the year to
  come. (Source: Drug Topics - Pharmacy News)</description>
            <author>Drug Topics - Pharmacy News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5507623</comments>
            <pubDate>Thu, 15 Dec 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5507623</guid>        </item>
        <item>
            <title>Get ready for short-cycle dispensing in LTC and skilled-nursing facilities</title>
            <link>http://www.medworm.com/index.php?rid=5507622&amp;cid=s_38385_34_f&amp;fid=38385&amp;url=http%3A%2F%2Fdrugtopics.modernmedicine.com%2Fdrugtopics%2FCommunity%2BPractice%2FGet-ready-for-short-cycle-dispensing-in-LTC-and-sk%2FArticleStandard%2FArticle%2Fdetail%2F752472%3FcontextCategoryId%3D47448%26ref%3D25</link>
            <description>Short-cycle dispensing for patients in long-term care and skilled-nursing facilities is mandated to
  begin in January 2013. The time to prepare is now. (Source: Drug Topics - Pharmacy News)</description>
            <author>Drug Topics - Pharmacy News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5507622</comments>
            <pubDate>Thu, 15 Dec 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5507622</guid>        </item>
        <item>
            <title>Pre-op aspirin use leads to decreased risk of post-op complications in cardiac surgery patients, study
    finds</title>
            <link>http://www.medworm.com/index.php?rid=5507621&amp;cid=s_38385_34_f&amp;fid=38385&amp;url=http%3A%2F%2Fdrugtopics.modernmedicine.com%2Fdrugtopics%2FTop%2BNews%2FPre-op-aspirin-use-leads-to-decreased-risk-of-post%2FArticleStandard%2FArticle%2Fdetail%2F752587%3FcontextCategoryId%3D47448%26ref%3D25</link>
            <description>Aspirin taken within 5 days of cardiac surgery led to a significant decrease in the risk of
  postoperative complications, according to a study published in the October issue of Annals of
  Surgery. (Source: Drug Topics - Pharmacy News)</description>
            <author>Drug Topics - Pharmacy News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5507621</comments>
            <pubDate>Thu, 15 Dec 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5507621</guid>        </item>
        <item>
            <title>Community pharmacists key to improving pain management</title>
            <link>http://www.medworm.com/index.php?rid=5507620&amp;cid=s_38385_34_f&amp;fid=38385&amp;url=http%3A%2F%2Fdrugtopics.modernmedicine.com%2Fdrugtopics%2FCommunity%2BPractice%2FCommunity-pharmacists-key-to-improving-pain-manage%2FArticleStandard%2FArticle%2Fdetail%2F752473%3FcontextCategoryId%3D47448%26ref%3D25</link>
            <description>In the underserved area of chronic pain management, community pharmacists have a tremendous
  opportunity to help patients manage pain more effectively. (Source: Drug Topics - Pharmacy News)</description>
            <author>Drug Topics - Pharmacy News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5507620</comments>
            <pubDate>Thu, 15 Dec 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5507620</guid>        </item>
        <item>
            <title>The polypharmacy dilemma</title>
            <link>http://www.medworm.com/index.php?rid=5507619&amp;cid=s_38385_34_f&amp;fid=38385&amp;url=http%3A%2F%2Fdrugtopics.modernmedicine.com%2Fdrugtopics%2FCommunity%2BPractice%2FThe-polypharmacy-dilemma%2FArticleStandard%2FArticle%2Fdetail%2F752465%3FcontextCategoryId%3D47448%26ref%3D25</link>
            <description>A Marin County pharmacy is working to improve community health by promoting patient education and MTM
  to patients who use several prescription drugs for chronic conditions. (Source: Drug Topics - Pharmacy News)</description>
            <author>Drug Topics - Pharmacy News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5507619</comments>
            <pubDate>Thu, 15 Dec 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5507619</guid>        </item>
        <item>
            <title>McKesson launches automated filling, dispensing solutions</title>
            <link>http://www.medworm.com/index.php?rid=5507618&amp;cid=s_38385_34_f&amp;fid=38385&amp;url=http%3A%2F%2Fdrugtopics.modernmedicine.com%2Fdrugtopics%2FTop%2BNews%2FMcKesson-launches-automated-filling-dispensing-sol%2FArticleStandard%2FArticle%2Fdetail%2F752586%3FcontextCategoryId%3D47448%26ref%3D25</link>
            <description>McKesson High Volume Solutions recently launched a high-speed, automated prescription filling system
  for ambulatory pharmacies and an automated medication dispensing cabinet. (Source: Drug Topics - Pharmacy News)</description>
            <author>Drug Topics - Pharmacy News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5507618</comments>
            <pubDate>Thu, 15 Dec 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5507618</guid>        </item>
        <item>
            <title>Compounding for Lyme disease</title>
            <link>http://www.medworm.com/index.php?rid=5507617&amp;cid=s_38385_34_f&amp;fid=38385&amp;url=http%3A%2F%2Fdrugtopics.modernmedicine.com%2Fdrugtopics%2FCommunity%2BPractice%2FCompounding-for-Lyme-disease%2FArticleStandard%2FArticle%2Fdetail%2F752477%3FcontextCategoryId%3D47448%26ref%3D25</link>
            <description>Lyme disease may be the most rewarding compounding niche that most pharmacists have never
  considered. (Source: Drug Topics - Pharmacy News)</description>
            <author>Drug Topics - Pharmacy News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5507617</comments>
            <pubDate>Thu, 15 Dec 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5507617</guid>        </item>
        <item>
            <title>Compounding pharmacies can help resolve drug shortages</title>
            <link>http://www.medworm.com/index.php?rid=5507616&amp;cid=s_38385_34_f&amp;fid=38385&amp;url=http%3A%2F%2Fdrugtopics.modernmedicine.com%2Fdrugtopics%2FTop%2BNews%2FCompounding-pharmacies-can-help-resolve-drug-short%2FArticleStandard%2FArticle%2Fdetail%2F752476%3FcontextCategoryId%3D47448%26ref%3D25</link>
            <description>More than 200 medications crucial to treatment of conditions such as leukemia, breast and colon
  cancer, and infectious diseases are in short supply in the United States. Compounding pharmacies can take up some
  of the slack. (Source: Drug Topics - Pharmacy News)</description>
            <author>Drug Topics - Pharmacy News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5507616</comments>
            <pubDate>Thu, 15 Dec 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5507616</guid>        </item>
        <item>
            <title>How to protect your pharmacy against drug-related crime</title>
            <link>http://www.medworm.com/index.php?rid=5507615&amp;cid=s_38385_34_f&amp;fid=38385&amp;url=http%3A%2F%2Fdrugtopics.modernmedicine.com%2Fdrugtopics%2FTop%2BNews%2FHow-to-protect-your-pharmacy-against-drug-related-%2FArticleStandard%2FArticle%2Fdetail%2F752475%3FcontextCategoryId%3D47448%26ref%3D25</link>
            <description>While pharmacy crime is nothing new, the rate of pharmacy crime is on the rise. Here are some
  suggestions for combating it successfully. (Source: Drug Topics - Pharmacy News)</description>
            <author>Drug Topics - Pharmacy News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5507615</comments>
            <pubDate>Thu, 15 Dec 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5507615</guid>        </item>
        <item>
            <title>Topical gel controls surgical bleeding</title>
            <link>http://www.medworm.com/index.php?rid=5507614&amp;cid=s_38385_34_f&amp;fid=38385&amp;url=http%3A%2F%2Fdrugtopics.modernmedicine.com%2Fdrugtopics%2FTop%2BNews%2FTopical-gel-controls-surgical-bleeding%2FArticleStandard%2FArticle%2Fdetail%2F752480%3FcontextCategoryId%3D47448%26ref%3D25</link>
            <description>FDA has approved a nontoxic gel that allows surgeons to temporarily stop blood flow during vascular
  and cardiovascular surgery without using clamps or elastic loops. (Source: Drug Topics - Pharmacy News)</description>
            <author>Drug Topics - Pharmacy News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5507614</comments>
            <pubDate>Thu, 15 Dec 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5507614</guid>        </item>
        <item>
            <title>Tipping the balance: Seven steps to managing stress</title>
            <link>http://www.medworm.com/index.php?rid=5507613&amp;cid=s_38385_34_f&amp;fid=38385&amp;url=http%3A%2F%2Fdrugtopics.modernmedicine.com%2Fdrugtopics%2FTop%2BNews%2FTipping-the-balance-Seven-steps-to-managing-stress%2FArticleStandard%2FArticle%2Fdetail%2F752471%3FcontextCategoryId%3D47448%26ref%3D25</link>
            <description>It doesn't take a lot of time or money to create some balance in your life, but it does take
  commitment and a willingness to change. (Source: Drug Topics - Pharmacy News)</description>
            <author>Drug Topics - Pharmacy News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5507613</comments>
            <pubDate>Thu, 15 Dec 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5507613</guid>        </item>
        <item>
            <title>New bills highlight the challenges of track-and-trace implementation</title>
            <link>http://www.medworm.com/index.php?rid=5507612&amp;cid=s_38385_34_f&amp;fid=38385&amp;url=http%3A%2F%2Fdrugtopics.modernmedicine.com%2Fdrugtopics%2FTop%2BNews%2FNew-bills-highlight-the-challenges-of-track-and-tr%2FArticleStandard%2FArticle%2Fdetail%2F752474%3FcontextCategoryId%3D47448%26ref%3D25</link>
            <description>Proposed legislation that would make &amp;#34;track-and-trace&amp;#34; prescription drug distribution
  systems mandatory has fueled new discussions among interested parties on both sides of the issue. (Source: Drug Topics - Pharmacy News)</description>
            <author>Drug Topics - Pharmacy News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5507612</comments>
            <pubDate>Thu, 15 Dec 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5507612</guid>        </item>
        <item>
            <title>FDA approves drugs for HIV, HAE</title>
            <link>http://www.medworm.com/index.php?rid=5507611&amp;cid=s_38385_34_f&amp;fid=38385&amp;url=http%3A%2F%2Fdrugtopics.modernmedicine.com%2Fdrugtopics%2FTop%2BNews%2FFDA-approves-drugs-for-HIV-HAE%2FArticleStandard%2FArticle%2Fdetail%2F752479%3FcontextCategoryId%3D47448%26ref%3D25</link>
            <description>FDA has approved a combination formulation of emtricitabine/rilpivirine/tenofovir to treat HIV-1
  infection in treatment-naive adults and icatibant to treat hereditary angioedema. (Source: Drug Topics - Pharmacy News)</description>
            <author>Drug Topics - Pharmacy News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5507611</comments>
            <pubDate>Thu, 15 Dec 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5507611</guid>        </item>
        <item>
            <title>The many sides of medication adherence</title>
            <link>http://www.medworm.com/index.php?rid=5507610&amp;cid=s_38385_34_f&amp;fid=38385&amp;url=http%3A%2F%2Fdrugtopics.modernmedicine.com%2Fdrugtopics%2FCommunity%2BPractice%2FMedication-adherence-and-public-health%2FArticleStandard%2FArticle%2Fdetail%2F752486%3FcontextCategoryId%3D47448%26ref%3D25</link>
            <description>Medication adherence issues have many implications for public health. (Source: Drug Topics - Pharmacy News)</description>
            <author>Drug Topics - Pharmacy News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5507610</comments>
            <pubDate>Thu, 15 Dec 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5507610</guid>        </item>
        <item>
            <title>Pfizer discounts Lipitor after atorvastatin launch</title>
            <link>http://www.medworm.com/index.php?rid=5507609&amp;cid=s_38385_34_f&amp;fid=38385&amp;url=http%3A%2F%2Fdrugtopics.modernmedicine.com%2Fdrugtopics%2FTop%2BNews%2FPfizer-discounts-Lipitor-after-atorvastatin-launch%2FArticleStandard%2FArticle%2Fdetail%2F752469%3FcontextCategoryId%3D47448%26ref%3D25</link>
            <description>Pfizer, Medco and pharmacy groups are all battling to be heard after a November article in the New
  York Times raised questions about the relative cost benefits of prescribing Lipitor or atorvastatin. (Source: Drug Topics - Pharmacy News)</description>
            <author>Drug Topics - Pharmacy News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5507609</comments>
            <pubDate>Thu, 15 Dec 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5507609</guid>        </item>
        <item>
            <title>AHRQ releases toolkit to help reduce adverse drug events</title>
            <link>http://www.medworm.com/index.php?rid=5507608&amp;cid=s_38385_34_f&amp;fid=38385&amp;url=http%3A%2F%2Fdrugtopics.modernmedicine.com%2Fdrugtopics%2FTop%2BNews%2FAHRQ-releases-toolkit-to-help-reduce-adverse-drug-%2FArticleStandard%2FArticle%2Fdetail%2F752585%3FcontextCategoryId%3D47448%26ref%3D25</link>
            <description>The Agency for Healthcare Research and Quality has released a new toolkit to help hospitals improve
  their medication reconciliation processes to reduce adverse drug events. (Source: Drug Topics - Pharmacy News)</description>
            <author>Drug Topics - Pharmacy News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5507608</comments>
            <pubDate>Thu, 15 Dec 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5507608</guid>        </item>
        <item>
            <title>FDA approves lower-dose topical oxybutynin gel 3% for overactive bladder</title>
            <link>http://www.medworm.com/index.php?rid=5507607&amp;cid=s_38385_34_f&amp;fid=38385&amp;url=http%3A%2F%2Fdrugtopics.modernmedicine.com%2Fdrugtopics%2FFDA%2FFDA-approves-lower-dose-topical-oxybutynin-gel-3-f%2FArticleStandard%2FArticle%2Fdetail%2F752643%3FcontextCategoryId%3D47448%26ref%3D25</link>
            <description>FDA has approved Antares' topical oxybutynin gel 3% product for the treatment of overactive bladder
  (OAB) with symptoms of urge urinary incontinence, urgency, and frequency. (Source: Drug Topics - Pharmacy News)</description>
            <author>Drug Topics - Pharmacy News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5507607</comments>
            <pubDate>Thu, 15 Dec 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5507607</guid>        </item>
        <item>
            <title>HHS secretary overrules FDA on widening availability of Plan B drug</title>
            <link>http://www.medworm.com/index.php?rid=5507628&amp;cid=s_38385_34_f&amp;fid=38385&amp;url=http%3A%2F%2Fwww.modernmedicine.com%2Fmodernmedicine%2FTop%2BNews%2FHHS-secretary-overrules-FDA-on-widening-availabili%2FArticleStandard%2FArticle%2Fdetail%2F752423%3FcontextCategoryId%3D47448%26ref%3D25</link>
            <description>Levonorgestrel (Plan B One-Step, Teva) will remain available by prescription only to adolescents aged
  16 years and younger after the Health and Human Services secretary overruled FDA&amp;rsquo;s recommendation to
  allow the emergency contraceptive to be sold over the counter. (Source: Drug Topics - Pharmacy News)</description>
            <author>Drug Topics - Pharmacy News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5507628</comments>
            <pubDate>Tue, 13 Dec 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5507628</guid>        </item>
        <item>
            <title>FDA, FTC act to remove HCG weight-loss products from market</title>
            <link>http://www.medworm.com/index.php?rid=5497028&amp;cid=s_38385_34_f&amp;fid=38385&amp;url=http%3A%2F%2Fdrugtopics.modernmedicine.com%2Fdrugtopics%2FTop%2BNews%2FFDA-FTC-act-to-remove-HCG-weight-loss-products-fro%2FArticleStandard%2FArticle%2Fdetail%2F752427%3FcontextCategoryId%3D47448%26ref%3D25</link>
            <description>FDA and the Federal Trade Commission have sent warning letters to several companies that are marketing
  homeopathic human chorionic gonadotropin products for weight loss. (Source: Drug Topics - Pharmacy News)</description>
            <author>Drug Topics - Pharmacy News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5497028</comments>
            <pubDate>Tue, 13 Dec 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5497028</guid>        </item>
        <item>
            <title>New formulation of extended-release opioid to be crush resistant</title>
            <link>http://www.medworm.com/index.php?rid=5497027&amp;cid=s_38385_34_f&amp;fid=38385&amp;url=http%3A%2F%2Fdrugtopics.modernmedicine.com%2Fdrugtopics%2FTop%2BNews%2FNew-formulation-of-extended-release-opioid-to-be-c%2FArticleStandard%2FArticle%2Fdetail%2F752425%3FcontextCategoryId%3D47448%26ref%3D25</link>
            <description>FDA approved a &amp;#34;crush-resistant&amp;#34; formulation of oxymorphone extended release (Opana
  ER, Endo Pharmaceuticals) with the intent to help patients with appropriate use of opioids. (Source: Drug Topics - Pharmacy News)</description>
            <author>Drug Topics - Pharmacy News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5497027</comments>
            <pubDate>Tue, 13 Dec 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5497027</guid>        </item>
        <item>
            <title>Teva introduces authorized generic birth-control pill</title>
            <link>http://www.medworm.com/index.php?rid=5497026&amp;cid=s_38385_34_f&amp;fid=38385&amp;url=http%3A%2F%2Fwww.modernmedicine.com%2Fmodernmedicine%2FTop%2BNews%2FTeva-introduces-authorized-generic-birth-control-p%2FArticleStandard%2FArticle%2Fdetail%2F752428%3FcontextCategoryId%3D47448%26ref%3D25</link>
            <description>Teva Pharmaceuticals announced in a prepared statement that levonorgestrel/ethinyl estradiol tablets
  (Camrese Lo) are now available. (Source: Drug Topics - Pharmacy News)</description>
            <author>Drug Topics - Pharmacy News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5497026</comments>
            <pubDate>Tue, 13 Dec 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5497026</guid>        </item>
        <item>
            <title>HHS secretary overrules FDA on widening availability of Plan B drug</title>
            <link>http://www.medworm.com/index.php?rid=5497025&amp;cid=s_38385_34_f&amp;fid=38385&amp;url=http%3A%2F%2Fdrugtopics.modernmedicine.com%2Fdrugtopics%2FTop%2BNews%2FHHS-secretary-overrules-FDA-on-widening-availabili%2FArticleStandard%2FArticle%2Fdetail%2F752423%3FcontextCategoryId%3D47448%26ref%3D25</link>
            <description>Levonorgestrel (Plan B One-Step, Teva) will remain available by prescription only to adolescents aged
  16 years and younger after the Health and Human Services secretary overruled FDA&amp;rsquo;s recommendation to
  allow the emergency contraceptive to be sold over the counter. (Source: Drug Topics - Pharmacy News)</description>
            <author>Drug Topics - Pharmacy News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5497025</comments>
            <pubDate>Tue, 13 Dec 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5497025</guid>        </item>
        <item>
            <title>Opposition to ESI/Medco merger is expressed at Senate hearing</title>
            <link>http://www.medworm.com/index.php?rid=5497024&amp;cid=s_38385_34_f&amp;fid=38385&amp;url=http%3A%2F%2Fdrugtopics.modernmedicine.com%2Fdrugtopics%2FTop%2BNews%2FOpposition-to-ESIMedco-merger-is-expressed-at-Sena%2FArticleStandard%2FArticle%2Fdetail%2F752424%3FcontextCategoryId%3D47448%26ref%3D25</link>
            <description>Pharmacy chains and organizations continue to actively oppose the merger of Express Scripts and Medco
  Health Solutions. (Source: Drug Topics - Pharmacy News)</description>
            <author>Drug Topics - Pharmacy News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5497024</comments>
            <pubDate>Tue, 13 Dec 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5497024</guid>        </item>
        <item>
            <title>U.S. Marshals seize Syntec dietary supplements</title>
            <link>http://www.medworm.com/index.php?rid=5497023&amp;cid=s_38385_34_f&amp;fid=38385&amp;url=http%3A%2F%2Fdrugtopics.modernmedicine.com%2Fdrugtopics%2FTop%2BNews%2FUS-Marshals-seize-Syntec-dietary-supplements%2FArticleStandard%2FArticle%2Fdetail%2F752426%3FcontextCategoryId%3D47448%26ref%3D25</link>
            <description>U.S. Marshals recently seized all dietary supplements manufactured by Syntec Inc. for false claims
  made by the company about the products&amp;rsquo; safety and effectiveness in treating various
  diseases. (Source: Drug Topics - Pharmacy News)</description>
            <author>Drug Topics - Pharmacy News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5497023</comments>
            <pubDate>Tue, 13 Dec 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5497023</guid>        </item>
        <item>
            <title>HHS secretary overrules FDA on widening availability of Plan B drug</title>
            <link>http://www.medworm.com/index.php?rid=5489240&amp;cid=s_38385_34_f&amp;fid=38385&amp;url=http%3A%2F%2Fdrugtopics.modernmedicine.com%2Fdrugtopics%2FFDA%2FHHS-secretary-overrules-FDA-on-widening-availabili%2FArticleStandard%2FArticle%2Fdetail%2F752266%3FcontextCategoryId%3D47448%26ref%3D25</link>
            <description>Levonorgestrel (Plan B One-Step, Teva) will remain available by prescription only to adolescents aged
  16 years and younger after the Health and Human Services secretary overruled FDA?s recommendation to allow the
  emergency contraceptive to be sold over the counter. (Source: Drug Topics - Pharmacy News)</description>
            <author>Drug Topics - Pharmacy News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5489240</comments>
            <pubDate>Sat, 10 Dec 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5489240</guid>        </item>
        <item>
            <title>Ranbaxy launches generic Caduet</title>
            <link>http://www.medworm.com/index.php?rid=5497029&amp;cid=s_38385_34_f&amp;fid=38385&amp;url=http%3A%2F%2Fwww.modernmedicine.com%2Fmodernmedicine%2FChains%2B%2526%2BBusiness%2FRanbaxy-launches-generic-Caduet%2FArticleStandard%2FArticle%2Fdetail%2F752111%3FcontextCategoryId%3D47448%26ref%3D25</link>
            <description>Ranbaxy has launched an authorized generic version of Caduet in the United States market, as part of
  an agreement with Pfizer. (Source: Drug Topics - Pharmacy News)</description>
            <author>Drug Topics - Pharmacy News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5497029</comments>
            <pubDate>Thu, 08 Dec 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5497029</guid>        </item>
        <item>
            <title>Abciximab-heparin combination treatment is no more effective than bivalirudin, study finds</title>
            <link>http://www.medworm.com/index.php?rid=5489245&amp;cid=s_38385_34_f&amp;fid=38385&amp;url=http%3A%2F%2Fdrugtopics.modernmedicine.com%2Fdrugtopics%2FTop%2BNews%2FAbciximab-heparin-combination-treatment-is-no-more%2FArticleStandard%2FArticle%2Fdetail%2F752043%3FcontextCategoryId%3D47448%26ref%3D25</link>
            <description>Abciximab plus unfractionated heparin was no more effective than bivalirudin at reducing risk of death
  or other events for patients with non&amp;ndash;ST-segment elevation myocardial infarction undergoing
  percutaneous coronary intervention, according to a study published online November 24 in the New England Journal of
  Medicine. (Source: Drug Topics - Pharmacy News)</description>
            <author>Drug Topics - Pharmacy News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5489245</comments>
            <pubDate>Thu, 08 Dec 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5489245</guid>        </item>
        <item>
            <title>Majority of emergency department visits are due to adverse drug reactions, study finds</title>
            <link>http://www.medworm.com/index.php?rid=5489244&amp;cid=s_38385_34_f&amp;fid=38385&amp;url=http%3A%2F%2Fdrugtopics.modernmedicine.com%2Fdrugtopics%2FTop%2BNews%2FMajority-of-emergency-department-visits-are-due-to%2FArticleStandard%2FArticle%2Fdetail%2F752038%3FcontextCategoryId%3D47448%26ref%3D25</link>
            <description>A surprisingly few medication classes are responsible for the majority of emergency department visits
  due to adverse drug reactions among U.S. adults aged 65 years and older, according to a study published in the
  November 24 issue of the New England Journal of Medicine. (Source: Drug Topics - Pharmacy News)</description>
            <author>Drug Topics - Pharmacy News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5489244</comments>
            <pubDate>Thu, 08 Dec 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5489244</guid>        </item>
        <item>
            <title>Statins show benefits years after treatment stops</title>
            <link>http://www.medworm.com/index.php?rid=5489243&amp;cid=s_38385_34_f&amp;fid=38385&amp;url=http%3A%2F%2Fdrugtopics.modernmedicine.com%2Fdrugtopics%2FTop%2BNews%2FStatins-show-benefits-years-after-treatment-stops%2FArticleStandard%2FArticle%2Fdetail%2F752042%3FcontextCategoryId%3D47448%26ref%3D25</link>
            <description>Long-term statin use is safe and effective, and it may continue to produce benefits without serious
  side effects years after patients stop taking the drugs, according to a study published online November 23 in The
  Lancet. (Source: Drug Topics - Pharmacy News)</description>
            <author>Drug Topics - Pharmacy News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5489243</comments>
            <pubDate>Thu, 08 Dec 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5489243</guid>        </item>
        <item>
            <title>Ranbaxy launches generic Caduet</title>
            <link>http://www.medworm.com/index.php?rid=5489242&amp;cid=s_38385_34_f&amp;fid=38385&amp;url=http%3A%2F%2Fdrugtopics.modernmedicine.com%2Fdrugtopics%2FChains%2B%2526%2BBusiness%2FRanbaxy-launches-generic-Caduet%2FArticleStandard%2FArticle%2Fdetail%2F752111%3FcontextCategoryId%3D47448%26ref%3D25</link>
            <description>Ranbaxy has launched an authorized generic version of Caduet in the United States market, as part of
  an agreement with Pfizer. (Source: Drug Topics - Pharmacy News)</description>
            <author>Drug Topics - Pharmacy News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5489242</comments>
            <pubDate>Thu, 08 Dec 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5489242</guid>        </item>
        <item>
            <title>The Joint Commission says texting orders is not appropriate</title>
            <link>http://www.medworm.com/index.php?rid=5489241&amp;cid=s_38385_34_f&amp;fid=38385&amp;url=http%3A%2F%2Fdrugtopics.modernmedicine.com%2Fdrugtopics%2FTop%2BNews%2FThe-Joint-Commission-says-texting-orders-is-not-ap%2FArticleStandard%2FArticle%2Fdetail%2F752045%3FcontextCategoryId%3D47448%26ref%3D25</link>
            <description>The Joint Commission recently issued a statement stating that it is not acceptable to text orders for
  patients to the hospital or other healthcare setting. The statement was in response to a question recently posed on
  the organization&amp;rsquo;s website. (Source: Drug Topics - Pharmacy News)</description>
            <author>Drug Topics - Pharmacy News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5489241</comments>
            <pubDate>Thu, 08 Dec 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5489241</guid>        </item>
        <item>
            <title>New NCPA program is designed to increase front-end profits</title>
            <link>http://www.medworm.com/index.php?rid=5479030&amp;cid=s_38385_34_f&amp;fid=38385&amp;url=http%3A%2F%2Fdrugtopics.modernmedicine.com%2Fdrugtopics%2FTop%2BNews%2FNew-NCPA-program-is-designed-to-increase-front-end%2FArticleStandard%2FArticle%2Fdetail%2F751561%3FcontextCategoryId%3D47448%26ref%3D25</link>
            <description>Maximizing profits at the front end of pharmacies&amp;rsquo; stores is the goal of a new National
  Community Pharmacists Association program. (Source: Drug Topics - Pharmacy News)</description>
            <author>Drug Topics - Pharmacy News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5479030</comments>
            <pubDate>Wed, 07 Dec 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5479030</guid>        </item>
        <item>
            <title>AMA launches medical information app</title>
            <link>http://www.medworm.com/index.php?rid=5479032&amp;cid=s_38385_34_f&amp;fid=38385&amp;url=http%3A%2F%2Fdrugtopics.modernmedicine.com%2Fdrugtopics%2FTop%2BNews%2FAMA-launches-medical-information-app%2FArticleStandard%2FArticle%2Fdetail%2F751563%3FcontextCategoryId%3D47448%26ref%3D25</link>
            <description>The American Medical Association has launched its second electronic application, &amp;ldquo;My
  Medications.&amp;rdquo; (Source: Drug Topics - Pharmacy News)</description>
            <author>Drug Topics - Pharmacy News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5479032</comments>
            <pubDate>Tue, 06 Dec 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5479032</guid>        </item>
        <item>
            <title>President George W. Bush to be keynote speaker at 2012 NACDS Annual Meeting</title>
            <link>http://www.medworm.com/index.php?rid=5479031&amp;cid=s_38385_34_f&amp;fid=38385&amp;url=http%3A%2F%2Fdrugtopics.modernmedicine.com%2Fdrugtopics%2FTop%2BNews%2FPresident-George-W-Bush-to-be-keynote-speaker-at-2%2FArticleStandard%2FArticle%2Fdetail%2F751562%3FcontextCategoryId%3D47448%26ref%3D25</link>
            <description>President George W. Bush will be the keynote speaker at the 2012 National Association of Chain Drug
  Stores (NACDS) Annual Meeting to be held in Palm Beach, Fla., April 21 to 24. (Source: Drug Topics - Pharmacy News)</description>
            <author>Drug Topics - Pharmacy News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5479031</comments>
            <pubDate>Tue, 06 Dec 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5479031</guid>        </item>
        <item>
            <title>ISMP cautions about new acetaminophen labeling for infants</title>
            <link>http://www.medworm.com/index.php?rid=5460751&amp;cid=s_38385_34_f&amp;fid=38385&amp;url=http%3A%2F%2Fdrugtopics.modernmedicine.com%2Fdrugtopics%2FTop%2BNews%2FISMP-cautions-about-new-acetaminophen-labeling-for%2FArticleStandard%2FArticle%2Fdetail%2F751024%3FcontextCategoryId%3D47448%26ref%3D25</link>
            <description>Liquid acetaminophen for infants is being shipped to hospitals and drug stores in new concentrations,
  even though manufacturers may not be providing notice about the concentration change, according to the Institute
  for Safe Medication Practices. (Source: Drug Topics - Pharmacy News)</description>
            <author>Drug Topics - Pharmacy News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5460751</comments>
            <pubDate>Thu, 01 Dec 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5460751</guid>        </item>
        <item>
            <title>Cancer drugs are in short supply in United States</title>
            <link>http://www.medworm.com/index.php?rid=5460750&amp;cid=s_38385_34_f&amp;fid=38385&amp;url=http%3A%2F%2Fdrugtopics.modernmedicine.com%2Fdrugtopics%2FTop%2BNews%2FCancer-drugs-are-in-short-supply-in-United-States%2FArticleStandard%2FArticle%2Fdetail%2F751026%3FcontextCategoryId%3D47448%26ref%3D25</link>
            <description>Some essential chemotherapy drugs are in short supply for the first time in the United States,
  according to the October 3 New England Journal of Medicine. (Source: Drug Topics - Pharmacy News)</description>
            <author>Drug Topics - Pharmacy News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5460750</comments>
            <pubDate>Thu, 01 Dec 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5460750</guid>        </item>
        <item>
            <title>Carville, Matlin to be keynote speakers at ASHP Midyear Clinical Meeting</title>
            <link>http://www.medworm.com/index.php?rid=5460749&amp;cid=s_38385_34_f&amp;fid=38385&amp;url=http%3A%2F%2Fdrugtopics.modernmedicine.com%2Fdrugtopics%2FTop%2BNews%2FCarville-Matlin-to-be-keynote-speakers-at-ASHP-Mid%2FArticleStandard%2FArticle%2Fdetail%2F751027%3FcontextCategoryId%3D47448%26ref%3D25</link>
            <description>Political mavens James Carville and Marlee Matlin will be the keynote speakers at this
  year&amp;rsquo;s American Society of Health Systems Pharmacists&amp;rsquo; Midyear Clinical
  Meeting. (Source: Drug Topics - Pharmacy News)</description>
            <author>Drug Topics - Pharmacy News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5460749</comments>
            <pubDate>Thu, 01 Dec 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5460749</guid>        </item>
        <item>
            <title>First generic version of cholesterol-lowering Lipitor approved</title>
            <link>http://www.medworm.com/index.php?rid=5460748&amp;cid=s_38385_34_f&amp;fid=38385&amp;url=http%3A%2F%2Fdrugtopics.modernmedicine.com%2Fdrugtopics%2FFDA%2FFirst-generic-version-of-cholesterol-lowering-Lipi%2FArticleStandard%2FArticle%2Fdetail%2F751131%3FcontextCategoryId%3D47448%26ref%3D25</link>
            <description>FDA approved the first generic version of the cholesterol-lowering drug Lipitor (atorvastatin calcium
  tablets). (Source: Drug Topics - Pharmacy News)</description>
            <author>Drug Topics - Pharmacy News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5460748</comments>
            <pubDate>Thu, 01 Dec 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5460748</guid>        </item>
        <item>
            <title>CDC launches new antibiotic tracking system</title>
            <link>http://www.medworm.com/index.php?rid=5460747&amp;cid=s_38385_34_f&amp;fid=38385&amp;url=http%3A%2F%2Fdrugtopics.modernmedicine.com%2Fdrugtopics%2FTop%2BNews%2FCDC-launches-new-antibiotic-tracking-system%2FArticleStandard%2FArticle%2Fdetail%2F751023%3FcontextCategoryId%3D47448%26ref%3D25</link>
            <description>The Centers for Disease Control and Prevention recently launched a new antibiotic tracking system,
  allowing hospitals to monitor their antibiotic use electronically. (Source: Drug Topics - Pharmacy News)</description>
            <author>Drug Topics - Pharmacy News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5460747</comments>
            <pubDate>Thu, 01 Dec 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5460747</guid>        </item>
        <item>
            <title>AHA, ACC release updated guidelines on secondary prevention of atherosclerotic vascular disease</title>
            <link>http://www.medworm.com/index.php?rid=5460746&amp;cid=s_38385_34_f&amp;fid=38385&amp;url=http%3A%2F%2Fdrugtopics.modernmedicine.com%2Fdrugtopics%2FTop%2BNews%2FAHA-ACC-release-updated-guidelines-on-secondary-pr%2FArticleStandard%2FArticle%2Fdetail%2F751025%3FcontextCategoryId%3D47448%26ref%3D25</link>
            <description>The American Heart Association and American College of Cardiology Foundation have issued new
  guidelines for secondary prevention and risk reduction in patients with atherosclerotic vascular
  disease. (Source: Drug Topics - Pharmacy News)</description>
            <author>Drug Topics - Pharmacy News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5460746</comments>
            <pubDate>Thu, 01 Dec 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5460746</guid>        </item>
        <item>
            <title>FDA mandates enhanced safety check on TNF blockers</title>
            <link>http://www.medworm.com/index.php?rid=5460745&amp;cid=s_38385_34_f&amp;fid=38385&amp;url=http%3A%2F%2Fdrugtopics.modernmedicine.com%2Fdrugtopics%2FTop%2BNews%2FFDA-mandates-enhanced-safety-check-on-TNF-blockers%2FArticleStandard%2FArticle%2Fdetail%2F751028%3FcontextCategoryId%3D47448%26ref%3D25</link>
            <description>FDA is requiring that manufacturers of tumor necrosis factor blockers perform enhanced safety
  surveillance in children, teenagers, and young adults, the agency said on November 3 in an ongoing safety review of
  this class of biologic products. (Source: Drug Topics - Pharmacy News)</description>
            <author>Drug Topics - Pharmacy News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5460745</comments>
            <pubDate>Thu, 01 Dec 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5460745</guid>        </item>
        <item>
            <title>Jaeger joins NACDS in newly created position</title>
            <link>http://www.medworm.com/index.php?rid=5460756&amp;cid=s_38385_34_f&amp;fid=38385&amp;url=http%3A%2F%2Fdrugtopics.modernmedicine.com%2Fdrugtopics%2FTop%2BNews%2FJaeger-joins-NACDS-in-newly-created-position%2FArticleStandard%2FArticle%2Fdetail%2F750563%3FcontextCategoryId%3D47448%26ref%3D25</link>
            <description>Pharmacy association veteran Kathleen Jaeger will publicly advance the role of pharmacists in patient
  care in a newly created position with the National Association of Chain Drug Stores. (Source: Drug Topics - Pharmacy News)</description>
            <author>Drug Topics - Pharmacy News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5460756</comments>
            <pubDate>Tue, 29 Nov 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5460756</guid>        </item>
        <item>
            <title>Provider groups file lawsuit against DHCS, HHS over Medicaid program cuts</title>
            <link>http://www.medworm.com/index.php?rid=5460755&amp;cid=s_38385_34_f&amp;fid=38385&amp;url=http%3A%2F%2Fdrugtopics.modernmedicine.com%2Fdrugtopics%2FTop%2BNews%2FProvider-groups-file-lawsuit-against-DHCS-HHS-over%2FArticleStandard%2FArticle%2Fdetail%2F750560%3FcontextCategoryId%3D47448%26ref%3D25</link>
            <description>Pharmacy and medical groups are suing the California Department of Health Care Services and the U.S.
  Department of Health and Human Services over the Centers for Medicare and Medicaid Services&amp;rsquo; recent
  approval of a 10% reimbursement rate cut in California&amp;rsquo;s Medicaid program. (Source: Drug Topics - Pharmacy News)</description>
            <author>Drug Topics - Pharmacy News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5460755</comments>
            <pubDate>Tue, 29 Nov 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5460755</guid>        </item>
        <item>
            <title>FDA approves first drug to treat specific type of insomnia</title>
            <link>http://www.medworm.com/index.php?rid=5460754&amp;cid=s_38385_34_f&amp;fid=38385&amp;url=http%3A%2F%2Fdrugtopics.modernmedicine.com%2Fdrugtopics%2FFDA%2FFDA-approves-first-drug-to-treat-specific-type-of-%2FArticleStandard%2FArticle%2Fdetail%2F750756%3FcontextCategoryId%3D47448%26ref%3D25</link>
            <description>FDA approved zolpidem tartrate sublingual tablets (Intermezzo, Transcept Pharmaceuticals) for use as
  needed to treat insomnia characterized by middle-of-the-night waking followed by difficulty returning to
  sleep. (Source: Drug Topics - Pharmacy News)</description>
            <author>Drug Topics - Pharmacy News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5460754</comments>
            <pubDate>Tue, 29 Nov 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5460754</guid>        </item>
        <item>
            <title>Number of patients taking dabigatran declines after first 4 months, study finds</title>
            <link>http://www.medworm.com/index.php?rid=5460753&amp;cid=s_38385_34_f&amp;fid=38385&amp;url=http%3A%2F%2Fdrugtopics.modernmedicine.com%2Fdrugtopics%2FTop%2BNews%2FNumber-of-patients-taking-dabigatran-declines-afte%2FArticleStandard%2FArticle%2Fdetail%2F750561%3FcontextCategoryId%3D47448%26ref%3D25</link>
            <description>Patients using the relatively new blood thinner dabigatran (Pradaxa, Boehringer Ingelheim) failed to
  remain on the treatment 17% of the time after the first 4 months, increasing their risk of stroke, according to a
  new study. (Source: Drug Topics - Pharmacy News)</description>
            <author>Drug Topics - Pharmacy News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5460753</comments>
            <pubDate>Tue, 29 Nov 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5460753</guid>        </item>
        <item>
            <title>Questions raised about prescribing atorvastatin, 180-day period costs</title>
            <link>http://www.medworm.com/index.php?rid=5460752&amp;cid=s_38385_34_f&amp;fid=38385&amp;url=http%3A%2F%2Fdrugtopics.modernmedicine.com%2Fdrugtopics%2FTop%2BNews%2FQuestions-raised-about-prescribing-atorvastatin-18%2FArticleStandard%2FArticle%2Fdetail%2F750562%3FcontextCategoryId%3D47448%26ref%3D25</link>
            <description>Pfizer, Medco, and pharmacy groups are all battling to get their voices heard after a November The New
  York Times article raised questions about prescribing Lipitor versus Atorvastatin (the new generic form of
  Lipitor). (Source: Drug Topics - Pharmacy News)</description>
            <author>Drug Topics - Pharmacy News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5460752</comments>
            <pubDate>Tue, 29 Nov 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5460752</guid>        </item>
        <item>
            <title>Diabetes: Monitoring and counseling patients with pre-diabetes and type 2 diabetes (CE)</title>
            <link>http://www.medworm.com/index.php?rid=5443747&amp;cid=s_38385_34_f&amp;fid=38385&amp;url=http%3A%2F%2Fdrugtopics.modernmedicine.com%2Fdrugtopics%2FChains%2B%2526%2BBusiness%2FDiabetes-Monitoring-and-counseling-patients-with-p%2FCME%2FArticle%2Fdetail%2F750141%3FcontextCategoryId%3D47448%26ref%3D25</link>
            <description>With 25.8 million Americans diagnosed as diabetic and an estimated 79 million more pre-diabetic, every
  pharmacist must be able to counsel patients and monitor progression. (Source: Drug Topics - Pharmacy News)</description>
            <author>Drug Topics - Pharmacy News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5443747</comments>
            <pubDate>Tue, 22 Nov 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5443747</guid>        </item>
        <item>
            <title>AHA, ACC release updated guidelines on secondary prevention of atherosclerotic vascular disease</title>
            <link>http://www.medworm.com/index.php?rid=5433729&amp;cid=s_38385_34_f&amp;fid=38385&amp;url=http%3A%2F%2Fdrugtopics.modernmedicine.com%2Fdrugtopics%2FTop%2BNews%2FAHA-ACC-release-updated-guidelines-on-secondary-pr%2FArticleStandard%2FArticle%2Fdetail%2F749892%3FcontextCategoryId%3D47448%26ref%3D25</link>
            <description>The American Heart Association and American College of Cardiology Foundation have issued new
  guidelines for secondary prevention and risk reduction in patients with atherosclerotic vascular
  disease. (Source: Drug Topics - Pharmacy News)</description>
            <author>Drug Topics - Pharmacy News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5433729</comments>
            <pubDate>Tue, 22 Nov 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5433729</guid>        </item>
        <item>
            <title>FDA appeals U.S. District Court ruling on pharmacy compounding</title>
            <link>http://www.medworm.com/index.php?rid=5433728&amp;cid=s_38385_34_f&amp;fid=38385&amp;url=http%3A%2F%2Fdrugtopics.modernmedicine.com%2Fdrugtopics%2FTop%2BNews%2FFDA-appeals-US-District-Court-ruling-on-pharmacy-c%2FArticleStandard%2FArticle%2Fdetail%2F749891%3FcontextCategoryId%3D47448%26ref%3D25</link>
            <description>FDA has appealed the September 2011 ruling made by the U.S. District Court for the Middle District of
  Florida in U.S. v. Franck&amp;rsquo;s Lab, Inc. The ruling had favored pharmacy compounding for veterinary
  patients. (Source: Drug Topics - Pharmacy News)</description>
            <author>Drug Topics - Pharmacy News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5433728</comments>
            <pubDate>Tue, 22 Nov 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5433728</guid>        </item>
        <item>
            <title>FDA approves aflibercept for patients with wet AMD</title>
            <link>http://www.medworm.com/index.php?rid=5433730&amp;cid=s_38385_34_f&amp;fid=38385&amp;url=http%3A%2F%2Fdrugtopics.modernmedicine.com%2Fdrugtopics%2FFDA%2FFDA-approves-aflibercept-for-patients-with-wet-AMD%2FArticleStandard%2FArticle%2Fdetail%2F749762%3FcontextCategoryId%3D47448%26ref%3D25</link>
            <description>FDA has approved aflibercept (Eylea Injection, Regeneron), known in the scientific literature as VEGF
  Trap-Eye, for the treatment of patients with neovascular (wet) age-related macular degeneration in patients aged 60
  and older at a recommended dose of 2 mg every 4 weeks (monthly) for the first 12 weeks, followed by 2 mg every 8
  weeks (2 months). (Source: Drug Topics - Pharmacy News)</description>
            <author>Drug Topics - Pharmacy News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5433730</comments>
            <pubDate>Mon, 21 Nov 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5433730</guid>        </item>
        <item>
            <title>FDA approves first drug to treat a rare bone marrow disease</title>
            <link>http://www.medworm.com/index.php?rid=5424413&amp;cid=s_38385_34_f&amp;fid=38385&amp;url=http%3A%2F%2Fdrugtopics.modernmedicine.com%2Fdrugtopics%2FFDA%2FFDA-approves-first-drug-to-treat-a-rare-bone-marro%2FArticleStandard%2FArticle%2Fdetail%2F749635%3FcontextCategoryId%3D47448%26ref%3D25</link>
            <description>FDA approved ruxolitinib (Jakafi, Incyte) for the treatment of patients with intermediate or high-risk
  myelofibrosis (MF), including primary MF, post-polycythemia vera MF, and post-essential thrombocythemia
  MF. (Source: Drug Topics - Pharmacy News)</description>
            <author>Drug Topics - Pharmacy News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5424413</comments>
            <pubDate>Sat, 19 Nov 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5424413</guid>        </item>
        <item>
            <title>FDA revokes breast cancer indication for bevacizumab</title>
            <link>http://www.medworm.com/index.php?rid=5424414&amp;cid=s_38385_34_f&amp;fid=38385&amp;url=http%3A%2F%2Fdrugtopics.modernmedicine.com%2Fdrugtopics%2FFDA%2FFDA-revokes-breast-cancer-indication-for-bevacizum%2FArticleStandard%2FArticle%2Fdetail%2F749600%3FcontextCategoryId%3D47448%26ref%3D25</link>
            <description>FDA Commissioner Margaret A. Hamburg, MD, announced the agency's decision to revoke the breast cancer
  indication for bevacizumab (Avastin), noting that the benefits do not outweigh the potentially life-threatening
  side effects, such as heart attack or heart failure, high blood pressure, bleeding and hemorrhaging, and the
  development of perforations in different parts of the body, such as the nose, stomach, and
  intestines. (Source: Drug Topics - Pharmacy News)</description>
            <author>Drug Topics - Pharmacy News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5424414</comments>
            <pubDate>Fri, 18 Nov 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5424414</guid>        </item>
        <item>
            <title>OTC Product News</title>
            <link>http://www.medworm.com/index.php?rid=5411954&amp;cid=s_38385_34_f&amp;fid=38385&amp;url=http%3A%2F%2Fdrugtopics.modernmedicine.com%2Fdrugtopics%2FTop%2BNews%2FOTC-Product-News%2FArticleStandard%2FArticle%2Fdetail%2F748790%3FcontextCategoryId%3D47448%26ref%3D25</link>
            <description>In this section we showcase products and product news that ran up against space limitations or fell
  outside the parameters of recently featured categories in the print edition. (Source: Drug Topics - Pharmacy News)</description>
            <author>Drug Topics - Pharmacy News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5411954</comments>
            <pubDate>Thu, 17 Nov 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5411954</guid>        </item>
        <item>
            <title>Fighting Alzheimer's</title>
            <link>http://www.medworm.com/index.php?rid=5411980&amp;cid=s_38385_34_f&amp;fid=38385&amp;url=http%3A%2F%2Fdrugtopics.modernmedicine.com%2Fdrugtopics%2FModern%2BMedicine%2BNow%2FFighting-Alzheimers%2FArticleStandard%2FArticle%2Fdetail%2F748866%3FcontextCategoryId%3D47448%26ref%3D25</link>
            <description>Alzheimer's disease is a devastating disorder that afflicts millions of Americans each year. With no
  cure in sight, research is focusing on prevention and disease modification. (Source: Drug Topics - Pharmacy News)</description>
            <author>Drug Topics - Pharmacy News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5411980</comments>
            <pubDate>Tue, 15 Nov 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5411980</guid>        </item>
    </channel>
</rss>

